<SEC-DOCUMENT>0001193805-25-001679.txt : 20251201
<SEC-HEADER>0001193805-25-001679.hdr.sgml : 20251201
<ACCEPTANCE-DATETIME>20251201070336
ACCESSION NUMBER:		0001193805-25-001679
CONFORMED SUBMISSION TYPE:	PREN14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20251201
FILED AS OF DATE:		20251201
DATE AS OF CHANGE:		20251201

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEA Industries Inc.
		CENTRAL INDEX KEY:			0001482541
		STANDARD INDUSTRIAL CLASSIFICATION:	AGRICULTURE SERVICES [0700]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				273911608
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0430

	FILING VALUES:
		FORM TYPE:		PREN14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41266
		FILM NUMBER:		251537116

	BUSINESS ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301
		BUSINESS PHONE:		303-993-5271

	MAIL ADDRESS:	
		STREET 1:		1780 55TH STREET, SUITE C
		CITY:			BOULDER
		STATE:			CO
		ZIP:			80301

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Surna Inc.
		DATE OF NAME CHANGE:	20100128

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			YZILabs Management Ltd.
		CENTRAL INDEX KEY:			0002098271
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			1231
		LEGAL ENTITY IDENTIFIER:    	98450075EDD8E1AE2D65

	FILING VALUES:
		FORM TYPE:		PREN14A

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		2ND FLOOR, WATER'S EDGE BUILDING
		STREET 2:		WICKHAMS CAY II
		CITY:			ROAD TOWN TORTOLA
		PROVINCE COUNTRY:   	D8
		ZIP:			VG1110
		BUSINESS PHONE:		54-9-11-4082-5010

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		2ND FLOOR, WATER'S EDGE BUILDING
		STREET 2:		PO BOX 2429 WICKHAMS CAY II
		CITY:			ROAD TOWN TORTOLA
		PROVINCE COUNTRY:   	D8
		ZIP:			VG1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>PREN14A
<SEQUENCE>1
<FILENAME>e665020_pren14a-ceai.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION<BR>
Washington, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">(Rule 14a-101)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>INFORMATION REQUIRED IN CONSENT
STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SCHEDULE 14A INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">Consent Statement Pursuant
to Section 14(a) of the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Filed by the Registrant &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Filed by a Party other than
the Registrant &#9746;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Preliminary
Consent Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitive
Consent Statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitive
Additional Materials</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Soliciting
Material Under Rule 14a-12</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; text-align: center; font-size: 10pt">CEA INDUSTRIES INC.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; font-size: 10pt">(Name of Registrant as Specified in Its Charter)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">YZILABS MANAGEMENT LTD.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">CHANGPENG ZHAO</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; font-size: 10pt">(Name of Persons(s) Filing Consent Statement, if Other Than the Registrant)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Payment of Filing Fee (Check
the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No
fee required</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fee
paid previously with preliminary materials</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fee
computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 1; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red">DATED
DECEMBER 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">YZILABS MANAGEMENT LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">___________, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Fellow BNC Stockholders:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">YZILabs Management Ltd. (&ldquo;YZi
Labs Management&rdquo;) and the other participants named herein (collectively, the &ldquo;YZi Labs,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo;
or &ldquo;us&rdquo;) beneficially own in the aggregate 2,150,481 shares of common stock, par value $0.00001 per share (the &ldquo;Common
Stock&rdquo;), of CEA Industries Inc., a Nevada corporation (&ldquo;BNC&rdquo; or the &ldquo;Company&rdquo;), representing approximately
5.03% of the outstanding shares of Common Stock. For the reasons set forth in the attached Consent Statement, we believe significant and
immediate changes to the composition of the Board of Directors of the Company (the &ldquo;Board&rdquo;) are necessary to address the continued
destruction of stockholder value at BNC and to ensure that the Company is being run in a manner consistent with your best interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We are therefore seeking your
support to materially reconstitute the Board by expanding the size of the Board by [<FONT STYLE="font-family: Wingdings">l</FONT>] members
to [<FONT STYLE="font-family: Wingdings">l</FONT>] directors in total and to elect our [<FONT STYLE="font-family: Wingdings">l</FONT>]
highly-qualified nominees as directors to the Board. We believe BNC stockholders deserve a Board that will truly look out for stockholders&rsquo;
best interest by meaningfully overseeing management, improving investor communications practices and ensuring management accountability.
We therefore feel compelled to take action to provide for a better future for all BNC stakeholders and to restore the confidence in the
Board that stockholders deserve. Accordingly, we urge you to join us in seeking to expand the size of the Board and elect YZi Lab&rsquo;s
[<FONT STYLE="font-family: Wingdings">l</FONT>] nominees, [<FONT STYLE="font-family: Wingdings">l</FONT>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">We believe the current Board
is in critical need of additional directors with the knowledge and experience to effectively oversee management, address the Company&rsquo;s
stock price underperformance and operational issues, and restore investors&rsquo; faith in the Company. The stockholders of BNC deserve
a well-functioning Board that understands its role as a steward of stockholder resources. We are therefore launching this consent solicitation
because we believe that stockholders must act <B><U>now</U></B> to prevent the further destruction of shareholder value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>We urge you to carefully
consider the information contained in the attached Consent Statement and then support our efforts by signing, dating and returning the
enclosed WHITE consent card today. The attached Consent Statement and the enclosed WHITE consent card are first being furnished to the
stockholders on or about [<FONT STYLE="font-family: Wingdings">l</FONT>], 2025. We urge you not to sign any revocation of consent card
that may be sent to you by BNC. If you have done so, you may revoke that revocation of consent by delivering a later dated WHITE consent
card to YZi Labs, in care of [<FONT STYLE="font-family: Wingdings">l</FONT>], which is assisting us, at the address listed on the following
page, or to the principal executive offices of BNC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B><BR></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">Thank you for your support,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 35%; border-bottom: Black 1pt solid; text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">YZILabs Management Ltd.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<DIV STYLE="padding: 1pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>If you have any questions,
require assistance in voting your <B>WHITE </B>consent card, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>or need additional copies
of YZi Labs&rsquo; proxy materials, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>please contact </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<I>at the phone numbers listed below.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<FONT STYLE="font-family: Wingdings">l</FONT>]&nbsp;</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in; color: red"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in; color: red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in; color: red"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in; color: red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red">DATED DECEMBER 1, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>CEA
INDUSTRIES INC.</B></FONT><B><BR>
_________________________<BR>
<BR>
CONSENT STATEMENT<BR>
OF</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">YZILABS MANAGEMENT LTD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>_________________________<BR>
<BR>
PLEASE SIGN, DATE AND MAIL THE ENCLOSED <U>WHITE</U> CONSENT CARD TODAY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Consent Statement and
the accompanying <B>WHITE</B> consent card are being furnished to you as a stockholder of CEA Industries Inc., a Nevada corporation (&ldquo;BNC&rdquo;
or the &ldquo;Company&rdquo;), by YZILabs Management Ltd., a British Virgin Islands business company (&ldquo;YZi Labs Management&rdquo;)
and the other participants named herein (collectively, &ldquo;YZi Labs,&rdquo; &ldquo;we,&rdquo; &ldquo;our&rdquo; or &ldquo;us&rdquo;),
in connection with our solicitation of written consents to expand the size of the Board of Directors of the Company (the &ldquo;Board&rdquo;)
by [<FONT STYLE="font-family: Wingdings">l</FONT>] members to [<FONT STYLE="font-family: Wingdings">l</FONT>] directors in total and elect
our [<FONT STYLE="font-family: Wingdings">l</FONT>] highly-qualified nominees as directors to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As significant stockholders
of the Company, with aggregate ownership of 2,150,481 shares of the Company&rsquo;s common stock, par value $0.00001 per share (the &ldquo;Common
Stock&rdquo;), constituting approximately 5.03% of the outstanding shares, we believe that the Board must be materially reconstituted
to ensure that the best interest of stockholders, the true owners of BNC, are appropriately represented in the boardroom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A solicitation of written
consents is a process that allows a company&rsquo;s stockholders to act by submitting written consents to any proposed stockholder action
in lieu of voting in person or by proxy at an annual or special meeting of stockholders. We are soliciting written consents from the holders
of shares of the Common Stock to take the following actions (each, as more fully described in this Consent Statement, a &ldquo;Proposal&rdquo;
and together, the &ldquo;Proposals&rdquo;), without a stockholders&rsquo; meeting, as authorized by the Nevada Revised Statutes (the &ldquo;NRS&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Proposal 1 </B>&ndash;
Repeal any provision of the Company&rsquo;s Bylaws, as amended (the &ldquo;Bylaws&rdquo;), in effect at the time this Proposal becomes
effective, including any amendments thereto, which were not included in the Bylaws that were in effect and were filed with the Securities
and Exchange Commission (the &ldquo;SEC&rdquo;) on July 25, 2025 (the &ldquo;Bylaw Restoration Proposal&rdquo;) to restore the Bylaws
to their current publicly disclosed form if the Board attempts to amend them in any manner prior to the completion of this consent solicitation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Proposal 2</B> &ndash;
Increase the size of the Board by [<FONT STYLE="font-family: Wingdings">l</FONT>] directors to [<FONT STYLE="font-family: Wingdings">l</FONT>]
directors in total pursuant to Article II, Section .02 of the Bylaws (the &ldquo;Board Size Proposal&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Proposal 3 </B>&ndash;
Amend Article II, Section .04 of the Bylaws to provide stockholders the exclusive ability to fill vacancies resulting from an increase
in the size of the Board by the vote or written consent of the Company&rsquo;s stockholders or by court order (the &ldquo;Vacancy Proposal&rdquo;);
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Proposal 4</B> &ndash;
Elect YZi Lab&rsquo;s [<FONT STYLE="font-family: Wingdings">l</FONT>] nominees: [<FONT STYLE="font-family: Wingdings">l</FONT>], to serve
as directors of the Company (the &ldquo;Nominees&rdquo;) (the &ldquo;Election Proposal&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Consent Statement and
the enclosed <B>WHITE</B> consent card are first being sent or given to the stockholders of BNC on or about [<FONT STYLE="font-family: Wingdings">l</FONT>],
2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are soliciting your consent
in favor of the adoption of the Board Size Proposal, the Vacancy Proposal and the Election Proposal because we believe the current Board
is in critical need of additional directors with the knowledge and experience to effectively oversee management, address the Company&rsquo;s
stock price underperformance and operational issues, and restore investors&rsquo; faith in the Company. In addition, we are soliciting
your consent in favor of the adoption of the Bylaw Restoration Proposal to ensure that the incumbent Board does not limit stockholders&rsquo;
ability to act by written consent, or limit the effect of your consent to the expansion of the Board and the election of the Nominees
through changes to the Bylaws not filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The effectiveness of each
of the Proposals requires the affirmative consent of the holders of a majority of the shares of Common Stock outstanding as of the close
of business on the Record Date (as defined below). Each Proposal will be effective without further action when we deliver to BNC such
requisite number of consents. Proposal 1, Proposal 2 and Proposal 3 are not subject to, or conditioned upon, the effectiveness of the
other Proposals. The effectiveness of Proposal 4 is conditioned upon the effectiveness of Proposal 2. If the size of the Board is not
increased, there will be no vacancies to fill, and the Nominees cannot be elected pursuant to Proposal 4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that our Nominees
comprise less than a majority of the Board following the Consent Solicitation, there can be no assurance that any actions or changes proposed
by our Nominees will be adopted or supported by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On [<FONT STYLE="font-family: Wingdings">l</FONT>],
2025, YZi Labs delivered a written request for the Board to fix a record date for determining stockholders entitled to give their written
consent to the Proposals. The Company has not yet publicly disclosed the record date for purposes of determining stockholders entitled
to give their written consent to the Proposals (the &ldquo;Record Date&rdquo;) or the number of shares of Common Stock outstanding as
of the Record Date, each of which is entitled to one consent on each Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>WE URGE YOU TO ACT TODAY TO
ENSURE THAT YOUR CONSENT WILL COUNT.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs reserves the right
to submit unrevoked written consents to BNC at any time after the receipt of the signed written consent. See &ldquo;Consent Procedures&rdquo;
for additional information regarding such procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date hereof, YZi
Labs collectively owns an aggregate of 2,150,481 shares of Common Stock, representing approximately 5.03% of the outstanding shares of
Common Stock. YZi Labs intends to consent in favor of the Proposals with respect to all of such shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs believes that there
were approximately 42,769,051 shares of Common Stock outstanding as of November 19, 2025, this figure is based upon 43,083,082 shares
of Common Stock outstanding as of September 18, 2025, which is the total number of shares outstanding as reported in the Company&rsquo;s
Quarterly Report on Form 10-Q filed with the SEC on September 22, 2025, after taking into account the share repurchases and share sales
disclosed in the Company&rsquo;s Current Report on Form 8-K filed with the SEC on November 19, 2025. The mailing address of the principal
executive offices of the Company is 385 South Pierce Avenue, Suite C, Louisville, Colorado 80027.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The failure to sign and return
a consent will have the same effect as voting against the Proposals. Please note that in addition to signing the enclosed WHITE consent
card, you must also date it to ensure its validity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>THIS CONSENT SOLICITATION
IS BEING MADE BY YZI LABS AND NOT BY OR ON BEHALF OF THE COMPANY. YZI LABS URGES YOU TO SIGN, DATE AND RETURN THE WHITE CONSENT CARD IN
FAVOR OF THE PROPOSALS DESCRIBED HEREIN.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>Important Notice Regarding
the Availability of Consent Materials for this consent solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>This Consent Statement is
available at [<FONT STYLE="font-family: Wingdings">l</FONT>].com</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>PLEASE READ THIS CAREFULLY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares of Common Stock
are registered in your own name, please submit your consent to us today by signing, dating and returning the enclosed <B>WHITE</B> consent
card in the postage-paid envelope provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you hold your shares in
&ldquo;street&rdquo; name with a bank, broker firm, dealer, trust company or other nominee, only they can exercise your right to consent
with respect to your shares of Common Stock and only upon receipt of your specific instructions. Accordingly, it is critical that you
promptly give instructions to consent to the Proposals to your bank, broker firm, dealer, trust company or other nominee. Please follow
the instructions to consent provided on the enclosed <B>WHITE</B> consent card. If your bank, broker firm, dealer, trust company or other
nominee provides for consent instructions to be delivered to them by telephone or Internet, instructions will be included on the enclosed
<B>WHITE</B> consent card. YZi Labs urges you to confirm in writing your instructions to the person responsible for your account and provide
a copy of those instructions to YZi Labs, c/o [<FONT STYLE="font-family: Wingdings">l</FONT>] (&ldquo;[<FONT STYLE="font-family: Wingdings">l</FONT>]&rdquo;)
so that we will be aware of all instructions given and can attempt to ensure that such instructions are followed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Execution and delivery of
a consent by a holder of shares of Common Stock will be presumed to be a consent with respect to all shares held by such holder unless
the consent specifies otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only holders of voting securities
of the Company as of the close of business on the Record Date will be entitled to consent to the Proposals. If you are a stockholder as
of the close of business on the Record Date, you will retain your right to consent even if you sell your shares of Common Stock after
the Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IF YOU TAKE NO ACTION, YOU
WILL IN EFFECT BE REJECTING THE PROPOSALS. ABSTENTIONS, FAILURES TO CONSENT AND BROKER NON-VOTES WILL HAVE THE SAME EFFECT AS WITHHOLDING
CONSENT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="padding: 1pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>If you have any questions,
require assistance in voting your <B>WHITE </B>consent card, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>or need additional copies
of YZi Labs&rsquo; proxy materials, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>please contact </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<I>at the phone numbers listed below.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>BACKGROUND TO THE SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">The following is a chronology
of our involvement at the Company to date and the material events leading up to this consent solicitation:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&bull;</TD>
    <TD>On July 28, 2025, the Company announced a $500,000,000 private placement offering (the &ldquo;PIPE&rdquo;), with the support of YZi Labs Management, to establish the Company as the largest publicly listed BNB Chain digital asset treasury strategy in the world.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Also on July 28, 2025, YZi Labs Management entered into a Securities Purchase Agreement (the &ldquo;Securities Purchase Agreement&rdquo;) and a Registration Rights Agreement (the &ldquo;Registration Rights Agreement&rdquo;) with the Company, each in connection with and to help ensure the successful closing of the PIPE.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On August 5, 2025, the Company announced the closing of the PIPE, that its stock ticker would be changed to &ldquo;BNC,&rdquo; and reiterated that the PIPE would support the implementation of the Company&rsquo;s BNB-focused treasury strategy. In connection with the closing of the PIPE, the Company entered into an asset management agreement (the &ldquo;Asset Management Agreement&rdquo;) with 10X Capital Partners LLC (&ldquo;10X Capital&rdquo;). Also on August 5, 2025, the Company entered into two Strategic Advisor Agreements (the &ldquo;Strategic Advisor Agreements&rdquo;) with each of 10X Capital and YZi Labs Management pursuant to which the Company engaged 10X Capital and YZi Labs Management to provide ongoing strategic advice and guidance relating to the Company&rsquo;s business and operations. Additionally, pursuant to its Strategic Advisor Agreement, 10X Capital received the right to nominate two individuals to the Board of Directors of the Company (&ldquo;the Board&rdquo;). Also on August 5, 2025, YZi Labs Management and 10X Capital entered into a Strategic Services Agreement pursuant to which YZi Labs Management would provide certain strategic advisory services to 10X Capital and receive a portion of the fees earned by 10X Capital under the Asset Management Agreement (the &ldquo;SSA&rdquo;).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Also on August 5, 2025, in connection with the closing of the PIPE, the Company announced that James R. Shipley, Matthew Tarallo, and Marion Mariathasan resigned as directors of the Company. The Company also announced that pursuant to the Board nomination rights granted by the Company to 10X Capital under its Strategic Advisor Agreement, on August 5, 2025, the Board appointed Hans Thomas, 10X Capital&rsquo;s Founding Partner, and Alexander Monje, 10X Capital&rsquo;s Partner and Chief Legal Officer, as directors of the Company to fill the vacancies created by the resignations.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Also on August 5, 2025, David Namdar, a Senior Partner at 10X Capital, became the Chief Executive Officer of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 7, 2025, representatives of YZi Labs contacted Mr. Thomas
regarding their concerns relating to the timing of investor updates and to express their views that the Company would benefit from increased
marketing efforts and media presence.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Since the closing the PIPE through the end of November 2025, representatives of YZi Labs have sought to privately engage with members of the Board and management of the Company to express their views and concerns on the Company&rsquo;s performance, operations and management, and to offer their views on the need for the Company to increase its marketing and media presence and provide more transparency to its shareholders regarding key information on its cryptocurrency holdings and the employment arrangements of Mr. Namdar, as the Company&rsquo;s CEO. During these discussions, YZi Labs has asked 10X Capital to lower the asset management fee under the AMA, and has offered on multiple occasions to waive the fees to which YZi Labs Management is entitled under the SSA, in order to reduce the Company&rsquo;s operational cost and help streamline and boost the performance of the Company. As of the date of this Consent Statement, YZi Labs Management has not received any compensation or any of the key information to which it is entitled under the SSA.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 14, 2025, representatives of YZi Labs contacted Mr. Thomas
regarding a potential offering and the expected timing of investor updates concerning the Company&rsquo;s BNB treasury.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 19, 2025, representatives of YZi Labs again contacted Mr.
Thomas regarding their concerns related to the timing and substance of investor updates and urged more timely and informative investor
updates.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 20, 2025, representatives of YZi Labs contacted Mr. Thomas
to express their concerns and views that the Company would benefit from increased marketing efforts and media presence.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On August 30, 2025, representatives of YZi Labs contacted Mr. Thomas
requesting a phone call to discuss their concerns and views related to the timing and substance of the Company&rsquo;s public updates
to investors and urging more timely and informative investor updates.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On September 2, 2025, the Company announced that Mr. Monje had resigned from the Board on August 29, 2025, and that the Board had appointed, Dr. Russell Read, the former Chief Investment Officer of 10X Capital to fill the resulting vacancy.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On September 10, 2025, representatives of YZi Labs contacted Messrs.
Thomas and Namdar to convey their serious concerns regarding Messrs. Thomas and Namdar&rsquo;s apparent and active involvement in fundraising
calls promoting another digital asset treasury project. Representatives of YZi Labs also expressed their belief that this may cause investors
to lose faith in the integrity of the Company&rsquo;s management and that the Company needed to promptly address these important concerns.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On September 15, 2025, the Company announced that its quarterly report and earnings announcement for the fiscal quarter ended July 31, 2025 would be delayed.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On September 18, 2025, representatives of YZi Labs introduced Messrs. Thomas and Namdar to potential candidates to join BNC&rsquo;s management that they believed would be beneficial to the Company and would help improve the Company&rsquo;s corporate governance and operations. Mr. Thomas indicated that they were reaching out to their counsel to discuss this possibility.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On September 21, 2025, Mr. Thomas again mentioned that they were going to discuss with their counsel regarding the potential candidates to join BNC&rsquo;s management.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On September 25, 2025, representatives of YZi Labs had dinner with
Mr. Namdar and other potential investors at a dinner in Seoul, Korea, during which YZi Labs expressed its significant concerns and view
that Mr.&nbsp;Namdar needed to allocate more time and attention to the management of the Company and its performance. YZi Labs also proposed
that, to help lower management cost and burdens to the Company, 10X Capital should lower their fees due under the Asset Management Agreement,
similar to YZi Lab Management&rsquo;s wavier of its fees.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On October 4, 2025, representatives of YZi Labs contacted Mr. Thomas expressing their concerns regarding the Company&rsquo;s lack of marketing efforts, and urging the Company to make more fulsome disclosure to its shareholders regarding the amount of BNB acquired, and the underperformance of BNC relative to BNB prices. Mr. Thomas indicated that the Company was in the process of discussing disclosures with its securities counsel and announcements would be forthcoming.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Also on October 4, 2025, representatives of YZi Labs contacted
Mr. Thomas to propose that Alex Odagiu, an investment partner at YZi Labs with significant crypto investment experience and extensive
traditional finance background, join the Company in order to improve the Company&rsquo;s management and expressed their concerns about
the management fee continued to be charged by 10X Capital under the Asset Management Agreement, and its impact and burdens on the Company&rsquo;s
operation.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&bull;</TD>
    <TD>On October 7, 2025, the Company announced that on October 1, 2025, the Board increased the size of the Board from four to five members, and appointed Carly E. Howard as a director of the Board, effective immediately.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Also on October 7, 2025, Mr. Odagiu had a phone call with Mr. Thomas and other representatives of YZi Labs where he expressed his views on how to improve the management of the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On October 8, 2025, Mr. Odagiu followed-up with Mr. Thomas on their discussion and highlighted several governance changes that he believed would be well received by shareholders, including management team adjustments, a more effective management incentive plan, and potential amendments to the Asset Management Agreement to lower or eliminate fees charged by 10X to the Company in addition to YZi Lab&rsquo;s fee waiver. However, the Company refused to add Mr. Odagiu to the management team or adopt his constructive suggestions for the Company.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On October 17, 2025, representatives of YZi Labs again contacted Mr.
Thomas regarding their concerns and views on the timing and substance of investor updates and urged more timely and informative investor
updates.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>Also on October 17, 2025, the Company announced that it had received a public reprimand letter from the Nasdaq Listing Qualifications Staff pursuant to Nasdaq Listing Rule 5810(c)(4), due to the Company&rsquo;s failure to comply with Nasdaq Listing Rule 5635(b) and that the Company thereafter regained compliance.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On November 6, 2025, YZi Labs sent a letter to the Company demanding that the Company remove and consequently revise its website, The Network (the &ldquo;Website&rdquo;), citing YZi Labs&rsquo; serious concerns regarding potential securities law violations.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD>On November 7, 2025, the Company removed the Website.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">In mid-November 2025, YZi Labs was informed that at a cryptocurrency
conference from November 10 to 12, 2025, Messrs. Namdar and Thomas were again promoting and seeking funding for DATs other than BNC.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On November 26, 2025, YZi Labs filed a preliminary consent statement
with the SEC, which was held by the EDGAR system due to technical issues.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">Also on November 26, 2025, YZi Labs filed a Schedule 13D disclosing
the preliminary consent statement.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On November 27, 2025, YZi Labs issued a press release announcing the
filing of the preliminary consent statement.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On November 28, 2025, the Company announced that the Board had approved
an increase in the size of the Board from five to six members and had appointed Annemarie Tierney to fill the resulting vacancy, each
effective as of November 26, 2025.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P>Also on November 28, 2025, representatives of the Company contacted representatives of YZi Labs regarding YZi Labs&rsquo;
Schedule 13D and press release.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&bull;</TD>
    <TD><P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">On December 1, 2025, YZi Labs filed this preliminary consent
        statement with the SEC.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt"></P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 13.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>QUESTIONS AND ANSWERS ABOUT
THIS CONSENT SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following are some of
the questions you, as a stockholder, may have and answers to those questions. The following is not meant to be a substitute for the information
contained in the remainder of this Consent Statement, and the information contained below is qualified by the more detailed descriptions
and explanations contained elsewhere in this Consent Statement. We urge you to carefully read this entire Consent Statement prior to making
any decision on whether to grant any consent hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHO IS MAKING THE SOLICITATION?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs is making this solicitation.
See &ldquo;Additional Participant Information&rdquo; for additional information regarding the Participants (as defined below) in this
consent solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHAT ARE THE PROPOSALS FOR
WHICH CONSENTS ARE BEING SOLICITED?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking you to consent
to four corporate actions: (1) the Bylaw Restoration Proposal, (2) the Board Size Proposal, (3) the Vacancy Proposal, and (4) the Election
Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs is asking you to
consent to the Board Size Proposal, the Vacancy Proposal and the Election Proposal to expand the size of the Board by [<FONT STYLE="font-family: Wingdings">l</FONT>]
directors and to elect our [<FONT STYLE="font-family: Wingdings">l</FONT>] Nominees to fill the resulting vacancies. In addition, in order
to ensure that you have the ability to act by written consent and that your consent to elect the Nominees will not be modified or diminished
by actions taken by the incumbent Board, YZi Labs is asking you to consent to the Bylaw Restoration Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHY ARE WE SOLICITING YOUR
CONSENT?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are soliciting your consent
because we believe the current Board is in critical need of additional directors with the knowledge and experience to effectively oversee
management, address the Company&rsquo;s stock price underperformance and operational issues, and restore investors&rsquo; faith in the
Company. We believe this consent solicitation is the best option we have available as stockholders to reject the status quo and correct
the Company&rsquo;s trajectory.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have identified highly
qualified candidates we believe would be able to serve the best interest of all stockholders by maximizing BNC&rsquo;s value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHO ARE THE NOMINEES?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking you to elect
each of [<FONT STYLE="font-family: Wingdings">l</FONT>] as a director of BNC. The business experience of our highly qualified Nominees
is set forth in this Consent Statement under the section entitled &ldquo;Proposal 4 &ndash; The Election Proposal,&rdquo; which we urge
you to read.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHAT IF NOT ALL OF THE PROPOSALS
ARE APPROVED?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While the election of any
of our Nominees pursuant to this Consent Solicitation is contingent on the passage of the Board Size Proposal, the opposite is not true
&ndash; the Bylaw Restoration Proposal, the Board Size Proposal and the Vacancy Proposal is not contingent upon the election of any of
our Nominees through this Consent Solicitation. A Nominee will not be elected pursuant to the Election Proposal if such Nominee does not
receive the affirmative consent of the holders of a majority of the outstanding shares in favor of such Nominee&rsquo;s election, even
if one or more of the other Nominees are each duly elected pursuant to the Election Proposal by a separate affirmative consent of the
holders of a majority of the outstanding shares in favor of one or more of such other Nominees&rsquo; election. If the Board Size Proposal
has been passed and one or more of the Nominees is not elected to the Board, one or more vacancies will remain on the Board following
the conclusion of the Consent Solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHO IS ELIGIBLE TO GRANT
WRITTEN CONSENTS IN FAVOR OF THE PROPOSALS?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders of voting securities
at the close of business on the Record Date have the right to consent to the Proposals. On [<FONT STYLE="font-family: Wingdings">l</FONT>],
2025, YZi Labs delivered a written request for the Board to fix the Record Date. The Company has not yet disclosed the new Record Date
or the number of shares of Common Stock outstanding as of the Record Date, each of which is entitled to one consent on each Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHEN IS THE DEADLINE FOR
SUBMITTING CONSENTS?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We urge you to submit your
consent as soon as possible. YZi Labs delivered its written consent to the Company on [<FONT STYLE="font-family: Wingdings">l</FONT>],
2025. While the NRS does not set forth a deadline by which we must submit valid, unrevoked consents representing a sufficient number of
shares of Common Stock to adopt the Proposals, we believe time is of the essence and we nevertheless intend to set [<FONT STYLE="font-family: Wingdings">l</FONT>],
2025 as the goal for submission of written consents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WE URGE YOU TO ACT AS SOON
AS POSSIBLE TO ENSURE THAT YOUR CONSENT WILL COUNT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>HOW MANY CONSENTS MUST BE
RECEIVED IN ORDER TO ADOPT THE PROPOSALS?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Proposals will be adopted
and become effective when properly completed, unrevoked consents are signed by the holders of a majority of the outstanding Common Stock
as of the close of business on the Record Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHAT SHOULD YOU DO TO SUPPORT
OUR PROPOSALS?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares of Common Stock
are registered in your own name, please submit your consent to us by signing, dating and returning the enclosed <B>WHITE</B> consent card
in the postage-paid envelope provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you hold your shares in
&ldquo;street&rdquo; name with a bank, broker firm, dealer, trust company or other nominee, only they can exercise your right to consent
with respect to your shares of Common Stock and only upon receipt of your specific instructions. Accordingly, it is critical that you
promptly give instructions to consent to the Proposals to your bank, broker firm, dealer, trust company or other nominee. Please follow
the instructions to consent provided on the enclosed <B>WHITE</B> consent card. If your bank, broker firm, dealer, trust company or other
nominee provides for consent instructions to be delivered to them by telephone or Internet, instructions will be included on the enclosed
<B>WHITE</B> consent card. We urge you to confirm in writing your instructions to the person responsible for your account and provide
a copy of those instructions to YZi Labs, c/o [<FONT STYLE="font-family: Wingdings">l</FONT>] so that we will be aware of all instructions
given and can attempt to ensure that such instructions are followed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>WHOM SHOULD YOU CALL IF YOU
HAVE QUESTIONS ABOUT THE SOLICITATION?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please call our solicitor
[<FONT STYLE="font-family: Wingdings">l</FONT>] toll-free at: [<FONT STYLE="font-family: Wingdings">l</FONT>] (Stockholders). Banks and
brokers call collect at: [<FONT STYLE="font-family: Wingdings">l</FONT>].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="padding: 1pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>If you have any questions,
require assistance in voting your <B>WHITE </B>consent card, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>or need additional copies
of YZi Labs&rsquo; proxy materials, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>please contact </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<I>at the phone numbers listed below.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>REASONS FOR OUR SOLICITATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WE BELIEVE THAT IMMEDIATE
AND MATERIAL CHANGE TO THE BOARD AND COMPANY MANAGEMENT IS REQUIRED TO UNLOCK SIGNIFICANT VALUE FOR ALL STOCKHOLDERS </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YOU HAVE AN OPPORTUNITY TO
SEND THE BOARD AND MANAGEMENT <U>A LOUD AND CLEAR MESSAGE </U>THAT STOCKHOLDERS WILL NOT TOLERATE THE VALUE-DESTRUCTIVE STATUS QUO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are a firm which invests
in companies with strong fundamentals and significant potential for long-term value creation. We are a significant stockholder of the
Company and a key contributor to the overall BNB ecosystem, who participated in the successful closing of the Company&rsquo;s $500,000,000
PIPE this summer because we believe in the Company&rsquo;s remarkable growth potential and the strength of its announced BNB-focused treasury
strategy. Although we have great hopes for the Company&rsquo;s future, we have become extremely concerned about the Company&rsquo;s underperformance
since the closing of the PIPE and fear that under the current leadership, stockholders will continue to watch their investment decline
until it is too late to put the Company back on the right path.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>We Believe Company Management
is Directly Responsible for the Company&rsquo;s Poor Performance</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite its advantageous market
position and strong fundamentals, BNC has significantly underperformed on several levels. Since the closing of the PIPE, the Company&rsquo;s
share price has significantly underperformed, despite the fact that the value of BNB, the primary asset of the Company&rsquo;s digital
asset treasury, has increased over the same time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image1.jpg" ALT="A graph showing the growth of a company&#10;&#10;AI-generated content may be incorrect." STYLE="height: 355px; width: 626px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Further, BNB has outperformed
other major digital assets since the beginning of 2025, which makes the Company&rsquo;s poor performance an apparent outlier and even
more concerning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image2.jpg" ALT="A graph of a line graph&#10;&#10;AI-generated content may be incorrect." STYLE="height: 346px; width: 621px"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Given that BNB, the Company&rsquo;s
digital asset treasury&rsquo;s primary asset is performing well, and the Company has an advantageous market position, especially with
YZi Labs Management being a significant investor in the Company, we believe that the Company&rsquo;s underperformance is primarily due
to its poor strategic execution, lack of media and marketing presence and an erosion of investor confidence in current management &ndash;
all of which has occurred with CEO, David Namdar at the Company&rsquo;s helm. For example, we were surprised and extremely concerned that
the Company took more time than any other similarly situated digital asset treasury (&ldquo;DAT&rdquo;) company in issuing its shelf registration
statement with respect to its at-the-market-offering (&ldquo;ATM&rdquo;), and thus failed to deliver its ATM on time, which we believe
is one of the most important factors driving DAT flywheel.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
For context, the Company promised investors that it would file its resale registration statement within 30 days following the closing
date of the PIPE, but it did not file until 53 days following the closing date. While we consented to an extension to the deadline to
file the initial registration statement under the Registration Rights Agreement in order to ensure the registration of the securities,
the Company&rsquo;s inability to timely complete fairly typical corporate actions integral to a public company, in our view, raises serious
concerns regarding company management and their ability to execute. To make matters worse, while these filings were pending, in our view
the Company repeatedly refused to provide sufficient communication with its investors, keeping them in the dark with respect to the liquidity
of and use of proceeds in connection with their investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>Company Management
has Repeatedly Failed to Engage the Market and Sufficiently Promote Itself and its Assets</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the Company
has not been sufficiently transparent with its stockholders regarding its actions, timing and has made little to no media or marketing
efforts to promote its assets. For instance, the Company has failed to alleviate the significant confusion amongst investors between BNB
Network Company and CEA Industries &ndash; the use of two names has created a lack of clarity which we believe needs to be corrected promptly.
Further, the Company has neglected to prepare several customary resources for stockholders to understand the Company&rsquo;s assets or
governance. In the almost four months since the closing of the PIPE, the Company has still not finished its Investor Relations webpage.
Additionally, the Company has failed to provide timely and meaningful updates regarding its NAV/NAV per share, mNAV, BNB yield generation
or BNB accumulation for several months. The Company only recently announced the launch of its treasury dashboard, a key investor communication
tool, which we urged the Company to adopt months ago, and which currently provides basic and materially insufficient information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>





<HR ALIGN="LEFT" SIZE="1" STYLE="width: 33%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>1</SUP></FONT>
Source: BNC, BMNR, SBET, ETHZ, FWDI, HSDT and STSS SEC filings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.3in; text-align: justify; text-indent: -0.3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There has been very little
media coverage on the Company, as there has been little to no activity on X (Twitter) or on other social media platforms, which we feel
is unusual for a DAT company. We believe the Company&rsquo;s apparent inability to adequately and effectively communicate with its investors
and the market further exacerbates investor confusion and significantly contributes to the Company underperformance. In the world of cryptocurrency,
marketing is of the utmost importance, and we believe there is no way for the Company to reach its true potential, without effective and
comprehensive marketing or investor outreach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>We Believe Management&rsquo;s
and Directors&rsquo; Interests are Not Aligned with Stockholders, and the Board has Failed in its Duty to Actively Oversee Management</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In our view, the interests
of Company management and the Board simply do not align with the interests of its stockholders. In particular, we have become concerned
regarding the inability of the Board and management to objectively monitor and manage the services being provided by 10X Capital, the
Company&rsquo;s asset manager, and its apparent failure to act independently in the best interest of the Company. Director Hans Thomas
is one of 10X Capital&rsquo;s Founding Partners, Director Russell Read is 10X Capital&rsquo;s former Chief Investment Officer and CEO
David Namdar is a Senior Partner at 10X Capital. We have serious concerns regarding Messrs. Thomas and Namdar&rsquo;s loyalty and amount
of dedication to the Company, as on more than one occasion, these individuals have significantly promoted other potential DATs, despite
failing to adequately promote BNC and BNB.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are concerned that Mr.
Namdar is more focused on serving the interests of 10X Capital, rather than advocating for the interests of all BNC stockholders. We also
have serious concerns that the Board as currently constituted lacks the experience or conviction to hold management accountable. In our
view, the Board also lacks sufficient the digital asset expertise necessary to drive and oversee the necessary strategic changes at the
Company. We believe that stockholders <B><U>need change now</U></B> and that the best way to ensure that the Company has the tools and
oversight necessary to improve its performance and restore investors&rsquo; faith in the Company is by adding additional competent, experienced
directors that can effectively lead the Company and oversee management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>A New Qualified Chief
Executive Officer and Experienced Management Team is Necessary </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon our experience,
a company cannot reach its full potential without a competent and committed CEO and a properly structured executive team. In addition
to the concerns regarding Mr. Namdar&rsquo;s performance and lack of devotion and loyalty to the Company, we believe BNC lacks an experienced
leadership team capable of supporting and executing the Company&rsquo;s strategy. The Company&rsquo;s continued refusal to include qualified
senior talent further undermines its capacity to deliver on its stated objectives. We believe that Mr. Namdar is simply unable and/or
unwilling to perform at the level necessary to execute upon BNC&rsquo;s current strategic initiatives and effectively lead BNC. Accordingly,
we believe that, if elected, the reconstituted Board should promptly undertake a thorough review of Mr.&nbsp;Namdar&rsquo;s performance
and should explore the selection of a new CEO with the expertise, commitment and independence necessary to lead the Company into the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><I>The Path Forward:
We Believe New Competent and Experienced Directors are Needed in the Boardroom NOW</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that time is of
the essence. Stockholders cannot afford the leadership of the current Board and management team. We urge all BNC stockholders to act now
to expand the size of the Board and add experienced competent directors to effectively oversee management, address the Company&rsquo;s
stock price underperformance and operational issues, in order to maximize value for all stockholders &ndash; the true owners of BNC. We
look forward to introducing our nominees shortly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROPOSAL 1 &ndash; THE BYLAW
RESTORATION PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are asking you to consent to the adoption of the Bylaw Restoration Proposal to ensure that the incumbent Board does not limit your ability
to act by written consent or limit the effect of your consent to increase the size of the Board to [</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]
directors and elect the Nominees to fill such newly created directorships through changes to the Bylaws not filed with the SEC on or before
July 25, 2025, which have the effect of limiting existing stockholders&rsquo; rights and abilities to take action in their capacity as
stockholders of BNC. The following is the text of the Bylaw Restoration Proposal: </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;RESOLVED, that any
provision of the Bylaws of CEA Industries Inc. as of the effectiveness of this resolution that was not included in the Bylaws, as amended
filed with the Securities and Exchange Commission on July 25, 2025, be and is hereby repealed.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the Bylaw Restoration
Proposal is to ensure that the Bylaws of the Company remain as they are in their current, publicly available form up until the completion
of this consent solicitation and to restore the Bylaws to their current form if the Board attempts to amend them in any manner prior to
the completion of this consent solicitation. If the Board does not effect any changes to the version of the Bylaws publicly available
in filings by the Company with the SEC on or before July 25, 2025, the Bylaw Restoration Proposal will have no further effect. However,
if the incumbent Board has made any changes since that time, such as amending the provision in the Bylaws permitting stockholders to act
by written consent, the Bylaw Restoration Proposal, if adopted, will restore the Bylaws to the version that was publicly available in
filings by BNC with the SEC on July 25, 2025, without considering the nature of any changes the incumbent Board may have adopted. As a
result, the Bylaw Restoration Proposal could have the effect of repealing bylaw amendments that one or more stockholders of the Company
may consider to be beneficial to them or to the Company. However, the Bylaw Restoration Proposal will not preclude the Board from reconsidering
any repealed bylaw changes following the consent solicitation. We are not currently aware of any specific bylaw provisions that would
be repealed by the adoption of the Bylaw Restoration Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YZI LABS URGES YOU TO CONSENT
TO THE BYLAW RESTORATION PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;<BR STYLE="clear: both">
<B>PROPOSAL 2 &ndash; THE BOARD SIZE PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking you to consent
to the Board Size Proposal to increase the size of the Board by [<FONT STYLE="font-family: Wingdings">l</FONT>] directors to [<FONT STYLE="font-family: Wingdings">l</FONT>]
directors in total.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is the text
of the Board Size Proposal:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;RESOLVED, that the
size of the Board of Directors of CEA Industries Inc. is increased by [<FONT STYLE="font-family: Wingdings">l</FONT>] directors to [<FONT STYLE="font-family: Wingdings">l</FONT>]
directors in total pursuant to Article II, Section .02 of the Bylaws, as amended.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the number of directors
currently serving on the Board is not expanded, we do not believe there will be any vacancies for which our Nominees can be elected to
fill. Accordingly, the Election Proposal is conditioned upon the approval by the stockholders of this Board Size Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>YZI LABS URGES YOU TO CONSENT
TO THE BOARD SIZE PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>PROPOSAL 3 &ndash; THE VACANCY
PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking you to consent
to the Vacancy Proposal to divest the current directors of their ability to fill vacancies on the Board resulting from an increase in
the size of the Board pursuant to a vote by or the written consent of the Company&rsquo;s stockholders or by court order, and to provide
stockholders with the exclusive ability to fill vacancies resulting from an increase in the size of the Board pursuant to a vote by or
the written consent of the Company&rsquo;s stockholders or by court order. Amending Article II, Section .04 of the Bylaws, as set forth
on <U>Schedule II</U> of this Consent Statement, will ensure that the stockholders have the exclusive ability to elect the directors to
fill the vacancies resulting from the Board Size Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YZI LABS URGES YOU TO CONSENT
TO THE VACANCY PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PROPOSAL 4 &ndash; THE ELECTION
PROPOSAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
believe the current Board is in critical need of additional directors with the knowledge and experience to effectively oversee management,
as discussed in further detail in the &ldquo;Reasons for the Solicitation&rdquo; section of this Consent Statement. Accordingly, YZi Labs
is asking you to consent to elect, without a stockholders&rsquo; meeting, each of the following individuals to serve as a director of
the Company: [</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">].</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Board is currently composed of six (6) directors, all of whom are elected annually. If the Board Size Proposal is approved, then the Board
will be increased to [</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">] directors
with [</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">] vacancies. All of
the Nominees, if elected, would fill those vacancies and each would hold office until the next annual meeting of stockholders and until
such person&rsquo;s successor has been elected or until such person&rsquo;s death, resignation, retirement or removal. If the Board Size
Proposal is approved and each of the Nominees is elected, then the Nominees will constitute a majority of the Board. There is no assurance
that any of the Company&rsquo;s incumbent directors will serve as directors if any of the Nominees are elected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THE NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following information
sets forth the name, age, business address, present principal occupation, and employment and material occupations, positions, offices,
or employments for the past five years of each of the Nominees. The specific experience, qualifications, attributes and skills that led
us to conclude that the Nominees should serve as directors of the Company is set forth in the bios below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Election Proposal to elect
the Nominees is conditioned upon the effectiveness of the Board Size Proposal. If the size of the Board is not increased pursuant to the
Board Size Proposal, there will be no vacancies to fill, and none of the Nominees can be elected pursuant to the Election Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although we have no reason
to believe that any of the Nominees will be unable or unwilling to serve as directors, if any of the Nominees are not available for election,
YZi Labs may designate such other nominee or nominees to be elected to the Board. In any such case, we would identify and properly designate
such substitute nominees in an amended Consent Statement and shares of Common Stock represented by the enclosed <B>WHITE</B> consent card
will be voted for such substitute nominee(s). Each of the Nominees has agreed to be named in this Consent Statement and to serve as a
director of the Company, if elected. The <B>WHITE</B> consent card delivered with this Consent Statement provides each stockholder with
the opportunity to approve the Election Proposal in part by designating the names of any of the Nominees whom such stockholder does not
want elected to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YZI LABS URGES YOU TO CONSENT
TO THE ELECTION OF ALL [</B><FONT STYLE="font-family: Wingdings">l</FONT><B>] OF THE NOMINEES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">CONSENT PROCEDURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 78.320 of the NRS
provides that, absent a contrary provision in a Nevada corporation&rsquo;s certification of incorporation or bylaws, any action required
or permitted to be taken at a meeting of the stockholders may be taken without a meeting if, before or after the action, a written consent
thereto is signed by stockholders holding at least a majority of the voting power, except that if a different proportion of voting power
is required for such an action at a meeting, then that proportion of written consents is required. Article III of the Bylaws provides
that any corporate action required by the Company&rsquo;s Articles of Incorporation, Bylaws, or under the NRS, to be voted upon or approved
at a duly called meeting of the shareholders, may be accomplished without a meeting if a written memorandum setting forth the action so
taken, shall be signed by holders of a majority of the total outstanding shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While Nevada law does not
set forth a deadline by which we must submit valid, unrevoked consents representing a sufficient number of shares of Common Stock to adopt
the Proposals, we nevertheless intend to set [<FONT STYLE="font-family: Wingdings">l</FONT>], 2025 as the goal for submission of written
consents. WE URGE YOU TO ACT TODAY TO ENSURE THAT YOUR CONSENT WILL COUNT. We reserve the right to submit received and unrevoked written
BNC consents at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Proposals become effective
as a result of this Consent Solicitation, the Company will be required to disclose the effectiveness of the stockholder actions within
four business days by filing a Current Report on Form 8-K with the SEC. YZi Labs also intends to notify stockholders as promptly as possible
by press release of the results of the Consent Solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Appraisal/Dissenter Rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Stockholders are not entitled
to appraisal or dissenters&rsquo; rights under Nevada law in connection with the Proposals or this Consent Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Revocation of Written Consents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">An executed consent card may
be revoked at any time by delivering a written consent revocation before the time that the action authorized by the executed consent becomes
effective. Revocations may only be made by the holder that granted such consent. A revocation may be in any written form validly signed
by the holder as long as it clearly states that the consent previously given is no longer effective. The delivery of a subsequently dated
<B>WHITE</B> consent card that is properly executed will constitute a revocation of any earlier consent. The revocation may be delivered
either to YZi Labs, in care of [<FONT STYLE="font-family: Wingdings">l</FONT>], or to the principal executive offices of BNC. Although
a revocation is effective if delivered to BNC, YZi Labs requests that either the original or photostatic copies of all revocations of
consents be mailed or delivered to YZi Labs, c/o [<FONT STYLE="font-family: Wingdings">l</FONT>], at the address set forth on the back
cover of this Consent Statement, so that YZi Labs will be aware of all revocations and can more accurately determine if and when sufficient
unrevoked consents to the actions described in this Consent Statement have been received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Procedural Instructions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You may consent to any of
the Proposals on the enclosed <B>WHITE </B>consent card by marking the &ldquo;CONSENT&rdquo; box and signing, dating and returning the
<B>WHITE </B>consent card in the envelope provided. You may also vote against consenting with respect to any one or more of the Proposals
on the enclosed <B>WHITE </B>consent card by marking the &ldquo;AGAINST CONSENT&rdquo; box, and signing, dating and returning the <B>WHITE
</B>consent card in the envelope provided. You may abstain from consenting to any of the Proposals on the enclosed <B>WHITE </B>consent
card by marking the &ldquo;ABSTAIN&rdquo; box and signing, dating and returning the <B>WHITE </B>consent card in the envelope provided.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you sign, date and return
the <B>WHITE </B>consent card, but give no direction with respect to certain of the Proposals, you will be deemed to consent to any such
Proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please note that in addition
to signing the enclosed <B>WHITE </B>consent card, you must also date it to ensure its validity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>YZI LABS URGES YOU TO CONSENT
TO <U>ALL</U> OF THE PROPOSALS ON THE ENCLOSED WHITE CONSENT CARD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B></B></P>

<!-- Field: Page; Sequence: 21; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SOLICITATION OF CONSENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The solicitation of consents
pursuant to this consent solicitation is being made by YZi Labs Management and the other Participants named herein. Consents may be solicited
by mail, facsimile, telephone, Internet, in person and by advertisements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs Management has entered
into an agreement with [<FONT STYLE="font-family: Wingdings">l</FONT>] for solicitation and advisory services in connection with this
solicitation, for which [<FONT STYLE="font-family: Wingdings">l</FONT>] will receive a fee not to exceed $[<FONT STYLE="font-family: Wingdings">l</FONT>],
together with reimbursement for its reasonable out-of-pocket expenses, and will be indemnified against certain liabilities and expenses,
including certain liabilities under the federal securities laws. [<FONT STYLE="font-family: Wingdings">l</FONT>] will solicit consents
from individuals, brokers, banks, bank nominees and other institutional holders. YZi Labs Management has requested banks, brokerage houses
and other custodians, nominees and fiduciaries to forward all solicitation materials to the beneficial owners of the shares of Common
Stock they hold. YZi Labs Management will reimburse these holders for their reasonable out-of-pocket expenses in so doing. It is anticipated
that [<FONT STYLE="font-family: Wingdings">l</FONT>] will employ approximately [<FONT STYLE="font-family: Wingdings">l</FONT>] persons
to solicit BNC stockholders as part of this solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The entire expense of this
consent solicitation is being borne by YZi Labs Management. Costs of this consent solicitation are currently estimated to be approximately
$[<FONT STYLE="font-family: Wingdings">l</FONT>]. YZi Labs Management estimates that through the date hereof its expenses in connection
with this consent solicitation are approximately $[<FONT STYLE="font-family: Wingdings">l</FONT>]. The actual amount could be higher or
lower depending on the facts and circumstances arising in connection with the solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">YZi Labs intends to seek reimbursement
from BNC of all expenses it incurs in connection with the solicitation. YZi Labs does not intend to submit the question of such reimbursement
to a vote of security holders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ADDITIONAL PARTICIPANT INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The participants in this solicitation
are YZi Labs Management, Changpeng Zhao, and each of the Nominees (each, a &ldquo;Participant&rdquo; and collectively, the &ldquo;Participants&rdquo;).
YZi Labs Management is a British Virgin Islands business company. Mr. Zhao is a citizen of Canada and the United Arab Emirates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal business of
YZi Labs Management is to invest in securities and fuel impact in Web3, AI and biotech. The principal business of Mr. Zhao is serving
as an entrepreneur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal business address
of each of YZi Labs Management and Mr. Zhao is 2<SUP>nd</SUP> Floor Water&rsquo;s Edge Building, Wickhams Cay II, Road Town, Tortola,
VG 1110, British Virgin Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date hereof, the
Participants beneficially own in the aggregate 2,150,481 shares of Common Stock. Excluded from the Participants&rsquo; beneficial ownership
are (i) 7,750,510 shares of Common Stock underlying the Pre-Funded Warrants, (ii) 9,900,991 shares of Common Stock underlying the Stapled
Warrants and (iii) 3,564,359 shares of Common Stock underlying the Strategic Advisor Warrants, which are each held by YZi Labs Management
as of the date hereof. Each of the Pre-Funded Warrants, the Stapled Warrants and the Strategic Advisor Warrants either provide or the
holder has elected that the holder shall not have the right to exercise any portion of any such warrants to the extent that after giving
effect to such issuance after exercise, such holder and certain of its affiliates would be deemed to beneficially own, as determined in
accordance with Section 13(d) of the Exchange Act, more than 4.99% of the Company&rsquo;s then outstanding shares of Common Stock (the
&ldquo;Beneficial Ownership Limitations&rdquo;). As of the date hereof, none of YZi Labs Management&rsquo;s Pre-Funded Warrants, Stapled
Warrants or Strategic Advisor Warrants are currently exercisable, and are not expected within 60 days to be exercisable due to the Beneficial
Ownership Limitations. Mr. Zhao, as the sole director of YZi Labs, has voting and investment control of the shares held by YZi Labs and
may be deemed to be the beneficial owner of such shares. Mr. Zhao disclaims any beneficial ownership of such securities not directly owned
by him.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each Participant, as a member
of a &ldquo;group&rdquo; with the other Participants for the purposes of Section 13(d)(3) of the Exchange Act, may be deemed to beneficially
own the shares of Common Stock owned in the aggregate by all of the Participants. Each Participant disclaims beneficial ownership of the
shares of Common Stock he, she or it does not directly own.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 28, 2025, in connection
with the PIPE, YZi Labs Management entered into the Securities Purchase Agreement and Registration Rights Agreement, pursuant to which
it purchased 2,150,481 shares of Common Stock at an offering price of $10.10 per share, 7,750,510 pre-funded warrants (the &ldquo;Pre-Funded
Warrants&rdquo;) at an offering price of $10.09999 per Pre-Funded Warrant and 9,900,991 stapled warrants (the &ldquo;Stapled Warrants&rdquo;)
at an exercise price of $15.15 per Stapled Warrant, and received certain registration rights in connection with the PIPE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 5, 2025, in connection
with the closing of the PIPE, YZi Labs Management entered into the Strategic Advisor Agreement, pursuant to which the Company engaged
YZi Labs Management to provide strategic advice and guidance relating to the Company&rsquo;s business, operations, growth initiatives
and industry trends in the crypto technology sector. Pursuant to the terms of the Strategic Advisor Agreement, the Company issued 3,564,359
strategic advisor warrants (the &ldquo;Strategic Advisor Warrants&rdquo;) to YZi Labs Management, with an exercise price equal to the
par value of the Common Stock. Also on August 5, 2025, YZi Labs Management entered into the SSA, pursuant to which YZi Labs Management
would provide certain strategic advisory services to 10X Capital and receive a portion of the fees earned by 10X Capital under the Asset
Management Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except for as otherwise disclosed
herein in connection with the PIPE, none of the Participants have engaged in any purchases or sales of securities of the Company during
the past two years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On [<FONT STYLE="font-family: Wingdings">l</FONT>],
the Participants entered into the Group Agreement. Pursuant to the terms of the Group Agreement, the Participants agreed, among other
things, to form the group for the purpose of working together to enhance stockholder value at the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 21, 2023, Mr.
Zhao pleaded guilty to a single count of Failure to Maintain an Effective Anti-Money Laundering Program in the U.S. District Court for
the Western District of Washington. Mr. Zhao was sentenced to four months in prison and assessed a $50 million fine. This marks the first
known instance that an individual with no criminal history was sentenced to prison for the same violation involving no allegations of
fraud or identifiable victims. On October 21, 2025, Mr. Zhao received a full and unconditional pardon from President Trump of the above-referenced
conviction. The Trump Administration has since justified Mr. Zhao&rsquo;s full and unconditional pardon by citing the unprecedented nature
of his prosecution and sentencing. When asked about his pardon of Mr. Zhao, President Trump stated that he was informed Mr. Zhao &ldquo;was
not guilty of anything,&rdquo; that &ldquo;what he did is not even a crime,&rdquo; and that &ldquo;he was persecuted by the Biden Administration.&rdquo;
Similarly, White House Press Secretary Karoline Leavitt explained that Mr. Zhao&rsquo;s prosecution was motivated by the previous Administration&rsquo;s
&ldquo;desire to punish the crypto industry.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr. Zhao is subject to a consent
order entered in <I>CFTC v. Zhao</I>, et al., in the U.S. District Court for the Northern District of Illinois. The consent order contains
conclusions&mdash;to which Mr. Zhao neither admitted nor denied&mdash;that Mr. Zhao was liable as a control person for certain compliance
violations of the Commodity Exchange Act committed by Binance and individually for willful evasion. This is the first time the CFTC brought
an enforcement action for willful evasion. Mr. Zhao was assessed a $150 million penalty.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 7, 2024, Mr. Zhao
was the subject of a Consent Order entered by Washington&rsquo;s Department of Financial Institutions Division of Consumer Services, which
prohibited him participating in the conduct of the affairs of a Washington money transmitter for five years from the date of entry of
the Consent Order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August 28, 2024, Mr. Zhao
was the subject of an Order of Prohibition issued by Michigan&rsquo;s Department of Insurance and Financial Services prohibiting him from
being a licensee, being employed by an agent of, or a control person of any licensee under the Money Transmission Services Act, or being
a licensee or registrant under the federal licensing act for a period of five years from the date of the Prohibition Order. Mr. Zhao has
since appealed the Prohibition Order, and his appeal is pending in the Michigan 30th Judicial Court for the County of Ingham (case number
24-766-AA).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 9, 2025, Mr. Zhao
was the subject of a Consent Order entered by the Georgia Department of Banking and Finance prohibiting him from applying for a Georgia
money transmitter license, controlling the affairs of a Georgia money transmitter, and acting as an ultimate equitable owner or executive
officer of a Georgia money transmitter. The stated duration of the prohibition terminates on the later of 5 years from the date of entry
of the Consent Order or until he receives a pardon, the latter of which he already received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On May 16, 2025, BAM Trading
Services Inc. executed a multistate settlement agreement (&ldquo;MSA&rdquo;) collectively resolving enforcement actions of participating
state regulators. Although Mr. Zhao is not a party to the MSA, the order prohibits Mr. Zhao from serving in any managerial role or otherwise
exerting a controlling influence over the management or policies of at BAM Trading Services Inc. or BAM Management US Holdings Inc. By
the terms of the MSA, these restrictions on Mr. Zhao were terminated on October 21, 2025, upon his receipt of a full and unconditional
pardon. Participating states included: Alabama, Arkansas, Arizona, Idaho, Iowa, Kentucky, Maryland, Minnesota, Nebraska, New Mexico, Oklahoma,
Rhode Island, South Carolina, Utah, Virginia, and West Virginia.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On November 3, 2025, Mr. Zhao
was the subject of a Final Order entered by Florida&rsquo;s Office of Financial Regulation (&ldquo;OFR&rdquo;) incorporating the terms
of a Stipulation and Consent Agreement (&ldquo;SCA&rdquo;) executed by OFR, Mr. Zhao, and BAM Trading Services, Inc. The SCA prohibits
Mr. Zhao from being appointed to any role subject to Fla. Stat. 560.141(1)(c) at BAM Trading Services, Inc. and BAM Management US Holdings.
However, the prohibitions have since been lifted according to the terms of the SCA, by virtue of Mr. Zhao&rsquo;s receipt of a full and
unconditional pardon from President Trump on October 21, 2025.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Except as set forth in this
Consent Statement (including the Schedules hereto), (i) during the past 10 years, no Participant in this solicitation has been convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors); (ii) no Participant in this solicitation directly or
indirectly beneficially owns any securities of the Company; (iii) no Participant in this solicitation owns any securities of the Company
which are owned of record but not beneficially; (iv) no Participant in this solicitation has purchased or sold any securities of the Company
during the past two years; (v) no part of the purchase price or market value of the securities of the Company owned by any Participant
in this solicitation is represented by funds borrowed or otherwise obtained for the purpose of acquiring or holding such securities; (vi)
no Participant in this solicitation is, or within the past year was, a party to any contract, arrangements or understandings with any
person with respect to any securities of the Company, including, but not limited to, joint ventures, loan or option arrangements, puts
or calls, guarantees against loss or guarantees of profit, division of losses or profits, or the giving or withholding of proxies; (vii)
no associate of any Participant in this solicitation owns beneficially, directly or indirectly, any securities of the Company; (viii)
no Participant in this solicitation owns beneficially, directly or indirectly, any securities of any parent or subsidiary of the Company;
(ix) no Participant or any of his or its associates or immediate family members was a party to any transaction, or series of similar transactions,
since the beginning of the Company&rsquo;s last fiscal year, or is a party to any currently proposed transaction, or series of similar
transactions, to which the Company or any of its subsidiaries was or is to be a party, in which the amount involved exceeds $120,000;
(x) no Participant in this solicitation or any of his or its associates has any arrangement or understanding with any person with respect
to any future employment by the Company or its affiliates, or with respect to any future transactions to which the Company or any of its
affiliates will or may be a party; and (xi) no Participant in this solicitation has a substantial interest, direct or indirect, by securities
holdings or otherwise, in any matter to be acted on in this solicitation. With respect to each of the Participants, except as set forth
elsewhere in this Consent Statement, none of the events enumerated in Item 401(f)(1)-(8) of Regulation S-K of the Exchange Act occurred
during the past 10 years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no material proceedings
to which any Participant in this solicitation or any of his or its associates is a party adverse to the Company or any of its subsidiaries
or has a material interest adverse to the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>OTHER MATTERS AND ADDITIONAL
INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Some banks, brokers and other
nominee record holders may be participating in the practice of &ldquo;householding&rdquo; consent statements and annual reports. This
means that only one copy of this Consent Statement may have been sent to multiple stockholders in your household. YZi Labs will promptly
deliver a separate copy of the document to you if you write to our solicitor, [<FONT STYLE="font-family: Wingdings">l</FONT>], at the
following address or phone number: [<FONT STYLE="font-family: Wingdings">l</FONT>], [<FONT STYLE="font-family: Wingdings">l</FONT>] (Stockholders),
[<FONT STYLE="font-family: Wingdings">l</FONT>] (Banks and Brokers). If you want to receive separate copies of our consent materials in
the future, or if you are receiving multiple copies and would like to receive only one copy for your household, you should contact your
bank, broker or other nominee record holder, or you may contact our solicitor at the above address and phone number.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>SPECIAL INSTRUCTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you were a record holder
of shares of Common Stock as of the close of business on the Record Date for this consent solicitation, you may elect to consent to, vote
against consenting to or abstain with respect to each Proposal by marking the &ldquo;CONSENT,&rdquo; &ldquo;AGAINST CONSENT&rdquo; or
&ldquo;ABSTAIN&rdquo; box, as applicable, underneath each Proposal on the accompanying <B>WHITE</B> consent card and signing, dating and
returning it promptly in the enclosed post-paid envelope.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>IF A STOCKHOLDER EXECUTES
AND DELIVERS A WHITE CONSENT CARD, BUT FAILS TO CHECK A BOX MARKED &ldquo;CONSENT,&rdquo; &ldquo;AGAINST CONSENT&rdquo; OR &ldquo;ABSTAIN&rdquo;
FOR A PROPOSAL, THAT STOCKHOLDER WILL BE DEEMED TO HAVE CONSENTED TO THAT PROPOSAL, EXCEPT THAT THE STOCKHOLDER WILL NOT BE DEEMED TO
CONSENT TO THE ELECTION OF ANY NOMINEE WHOSE NAME IS WRITTEN IN THE SPACE THE APPLICABLE INSTRUCTION TO THE ELECTION PROPOSAL PROVIDES
ON THE CARD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>YOUR CONSENT IS IMPORTANT.
PLEASE SIGN AND DATE THE ENCLOSED WHITE CONSENT CARD AND RETURN IT IN THE ENCLOSED POST-PAID ENVELOPE PROMPTLY. YOU MUST DATE YOUR CONSENT
IN ORDER FOR IT TO BE VALID. FAILURE TO SIGN, DATE AND RETURN YOUR CONSENT WILL HAVE THE SAME EFFECT AS VOTING AGAINST THE PROPOSALS.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">If
your shares are held in the name of a brokerage firm, bank nominee or other institution, only it can execute a consent with respect to
those shares of Common Stock and only on receipt of specific instructions from you. Thus, you should contact the person responsible for
your account and give instructions for the <B>WHITE</B> consent card to be signed representing your shares. You should confirm in writing
your instructions to the person responsible for your account and provide a copy of those instructions to </FONT>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<FONT STYLE="font-family: Times New Roman, Times, Serif">at the address below, so that we will be aware of all instructions given and
can attempt to ensure that those instructions are followed. If you have any questions or require any assistance in executing your consent,
please call </FONT>[<FONT STYLE="font-family: Wingdings">l</FONT>] <FONT STYLE="font-family: Times New Roman, Times, Serif">at the numbers
listed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="padding: 1pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>If you have any questions,
require assistance in voting your <B>WHITE </B>consent card, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>or need additional copies
of YZi Labs&rsquo; proxy materials, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>please contact </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<I>at the phone numbers listed below.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>CERTAIN ADDITIONAL INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WE HAVE OMITTED FROM THIS
CONSENT STATEMENT CERTAIN DISCLOSURE REQUIRED BY APPLICABLE LAW THAT IS EXPECTED TO BE INCLUDED IN A CONSENT REVOCATION STATEMENT TO BE
FILED BY THE COMPANY RELATING TO THE PROPOSALS DESCRIBED HEREIN BASED ON OUR RELIANCE ON RULE 14A-5(C) UNDER THE EXCHANGE ACT. THIS DISCLOSURE
IS EXPECTED TO INCLUDE, AMONG OTHER THINGS, CURRENT BIOGRAPHICAL INFORMATION ON THE COMPANY&rsquo;S DIRECTORS AND EXECUTIVE OFFICERS,
INFORMATION CONCERNING EXECUTIVE COMPENSATION AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE COMMITTEES OF THE BOARD AND OTHER
INFORMATION CONCERNING THE BOARD, INFORMATION CONCERNING CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS, INFORMATION ABOUT THE COMPANY&rsquo;S
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND OTHER IMPORTANT INFORMATION. SEE SCHEDULE I FOR INFORMATION REGARDING PERSONS WHO BENEFICIALLY
OWN MORE THAN 5% OF THE SHARES AND THE OWNERSHIP OF THE SHARES BY THE DIRECTORS AND MANAGEMENT OF THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information concerning
the Company contained in this Consent Statement and the Schedules attached hereto has been taken from, or is based upon, publicly available
information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify; text-indent: 0in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="width: 50%">&nbsp;</TD>
  <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B>YZILabs Management
Ltd. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><B><BR>
</B>[<FONT STYLE="font-family: Wingdings">l</FONT>]<B>, 2025</B></P>
</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 238.5pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>SCHEDULE I</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>The following is reprinted
from the Company&rsquo;s</I> <FONT STYLE="background-color: white">[<FONT STYLE="font-family: Wingdings">l</FONT>] <I>filed with the Securities
and Exchange Commission on </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]<I>. </I></FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<!-- Field: Page; Sequence: 27; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>SCHEDULE II</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>PROPOSED AMENDMENT TO THE
BYLAWS, AS AMENDED, OF CEA INDUSTRIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">1.</TD><TD STYLE="width: 20pt"></TD><TD STYLE="text-align: justify">Proposed amendment to Article II, Section .04 of the Bylaws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">Article II, Section
.04 of the Bylaws of the Company is amended by deleting the section in its entirety and replacing it with the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">.04 Vacancies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">In case of any vacancy
in the Board of Directors, the remaining Directors, whether constituting a quorum or not, may elect a successor to hold office for the
unexpired portion of the terms of the Directors whose place shall be vacant, and until his/her successor shall have been duly elected
and qualified. Further, the remaining Directors may fill any empty seats on the Board of Directors even if the empty seats have never
been occupied. Notwithstanding the foregoing, a vacancy in the Board of Directors created by an increase in the size of the Board of Directors
by the vote or written consent of the shareholders may be filled only by the vote of a majority of the shares entitled to vote represented
at a duly held meeting of shareholders at which a quorum is present, or by the written consent of holders of a majority of the total outstanding
shares entitled to vote. Each Director so elected shall hold office until the next annual meeting of shareholders and until his/her successor
has been elected and qualified.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 28; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-1</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>IMPORTANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Tell your Board what you think!
YOUR CONSENT IS VERY IMPORTANT, no matter how many or how few shares you own. Please &ldquo;<B>CONSENT</B>&rdquo; to each of the Proposals
by taking three steps:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">SIGNING the enclosed <B><U>WHITE</U></B> consent card,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">DATING the enclosed <B><U>WHITE</U></B> consent card, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 57pt"></TD><TD STYLE="width: 15pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">MAILING the enclosed <B><U>WHITE</U></B> consent card TODAY in the envelope provided (no Postage is required
if mailed in the United States).</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>If any of your shares are
held in the name of a broker, bank, bank nominee, or other institution, only it can give consent for your shares and only upon receipt
of your specific instructions.</B> Depending upon your broker or custodian, you may be able to give consent either by toll-free telephone
or by the Internet. You may also give consent by signing, dating and returning the enclosed <B><U>WHITE</U></B> consent card in the postage-paid
envelope provided, and to ensure that your consent is given for your shares, you should also contact the person responsible for your account
and give instructions for a <B><U>WHITE</U></B> consent card to be issued representing your shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">After signing the enclosed
<B><U>WHITE</U></B> consent card, <B>DO NOT SIGN OR RETURN BNC&rsquo;S CONSENT REVOCATION CARD UNLESS YOU INTEND TO CHANGE YOUR CONSENT
INSTRUCTIONS</B>, because only your latest dated consent card will be counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have previously signed
and returned a [<FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT> consent
revocation card to BNC, you have every right to change your consent instructions. Only your latest dated consent card will count. You
may cancel any consent revocation card already sent to BNC by signing, dating and mailing the enclosed <B><U>WHITE</U></B> consent card
in the postage-paid envelope provided or by giving consent by telephone or Internet. Any consent revocation may be cancelled at any time
prior to our delivery of written consents to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>If you have any questions
concerning this Consent Statement, would like to request additional copies of this Consent Statement or need help giving consent for your
shares, please contact our consent solicitor:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<DIV STYLE="padding: 1pt; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>If you have any questions,
require assistance in voting your <B>WHITE </B>consent card, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>or need additional copies
of YZi Labs&rsquo; proxy materials, </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>please contact </I>[<FONT STYLE="font-family: Wingdings">l</FONT>]
<I>at the phone numbers listed below.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<FONT STYLE="font-family: Wingdings">l</FONT>]</P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red"><B>PRELIMINARY COPY
SUBJECT TO COMPLETION<BR>
DATED DECEMBER 1, 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in; color: red">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>WHITE CONSENT CARD<BR>
<BR>
CONSENT OF STOCKHOLDERS OF CEA INDUSTRIES INC. TO ACTION WITHOUT A MEETING:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>THIS CONSENT IS SOLICITED
<FONT STYLE="font-family: Times New Roman, Times, Serif">BY YZILABS MANAGEMENT LTD. </FONT>AND THE OTHER PARTICIPANTS NAMED IN ITS CONSENT
SOLICITATION (COLLECTIVELY, &ldquo;YZI LABS&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>THE BOARD OF DIRECTORS OF
CEA INDUSTRIES INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>IS NOT SOLICITING THIS CONSENT<BR>
<BR>
C&nbsp;&nbsp;&nbsp;O&nbsp;&nbsp;&nbsp;N&nbsp;&nbsp;&nbsp;S&nbsp;&nbsp;&nbsp;E&nbsp;&nbsp;&nbsp;N&nbsp;&nbsp;&nbsp;T<BR>
<BR>
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Unless otherwise indicated below,
the undersigned, a stockholder of record of CEA Industries Inc. (the &ldquo;Company&rdquo;), hereby consents pursuant to Section&nbsp;78.320
of the Nevada Revised Statutes with respect to all shares of the Company&rsquo;s common stock, par value $0.00001 per share (the &ldquo;Shares&rdquo;)
held by the undersigned to the taking of the following actions without a meeting of the stockholders of the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>IF THIS WHITE CONSENT CARD
IS SIGNED AND RETURNED, IT WILL BE VOTED IN ACCORDANCE WITH YOUR INSTRUCTIONS. IF NO BOX IS MARKED FOR A PROPOSAL, THE UNDERSIGNED WILL
BE DEEMED TO CONSENT TO SUCH PROPOSAL, EXCEPT THAT THE UNDERSIGNED WILL NOT BE DEEMED TO CONSENT TO THE ELECTION OF ANY NOMINEE WHOSE
NAME IS WRITTEN IN THE SPACE PROVIDED. YZI LABS RECOMMENDS THAT YOU <U>CONSENT</U> TO PROPOSALS 1-4.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">1</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Repeal any provision of the Company&rsquo;s Bylaws, as amended (the &ldquo;Bylaws&rdquo;)
in effect at the time this Proposal becomes effective, including any amendments thereto, which were not included in the Bylaws that were
in effect and filed with the Securities and Exchange Commission on July 25, 2025.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; text-indent: 0in; font-size: 10pt">Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Against Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Abstain</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">2.</TD><TD STYLE="text-align: left; width: 5pt"></TD><TD STYLE="text-align: left">Increase the size of the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) by
[<FONT STYLE="font-family: Wingdings">l</FONT>] directors to [<FONT STYLE="font-family: Wingdings">l</FONT>] directors in total pursuant to Article II, Section .02 of the Bylaws.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; text-indent: 0in; font-size: 10pt">Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Against Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Abstain</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
</TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">3.</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Amend Article II, Section .04 of the Bylaws to provide stockholders the exclusive ability
to fill vacancies resulting from an increase in the size of the Board by the vote or written consent of the Company&rsquo;s stockholders
or by court order.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; text-indent: 0in; font-size: 10pt">Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Against Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Abstain</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
</TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 15pt; text-align: left">4.</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify">Elect [<FONT STYLE="font-family: Wingdings">l</FONT>] to serve as directors of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 34%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD>
    <TD STYLE="vertical-align: top; width: 33%; text-align: center; text-indent: 0in; font-size: 10pt">&#9744;</TD></TR>
  <TR>
    <TD STYLE="text-align: center; text-indent: 0in; font-size: 10pt">Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Against Consent</TD>
    <TD STYLE="vertical-align: top; text-align: center; text-indent: 0in; font-size: 10pt">Abstain</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 30; Value: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: right; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>INSTRUCTION: TO CONSENT,
VOTE AGAINST CONSENTING OR ABSTAIN FROM CONSENTING TO THE ELECTION OF ALL THE PERSONS NAMED IN PROPOSAL 4, CHECK THE APPROPRIATE BOX ABOVE.
IF YOU WISH TO CONSENT TO THE ELECTION OF CERTAIN OF THE PERSONS NAMED IN PROPOSAL 4, BUT NOT ALL OF THEM, CHECK THE &ldquo;CONSENT&rdquo;
BOX ABOVE AND WRITE THE NAME OF EACH SUCH PERSON YOU&nbsp;<U>DO NOT</U>&nbsp;WISH ELECTED IN THE SPACE PROVIDED BELOW.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: center; text-indent: 0in"><BR>
<B>__________________________________________________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1in; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Proposal 1, Proposal 2 and
Proposal 3 are not subject to, or conditioned upon, the effectiveness of the other Proposals. The effectiveness of Proposal 4 is conditioned
upon the effectiveness of Proposal 2. If the size of the Board is not increased, there will be no vacancies to fill, and the Nominees
cannot be elected pursuant to Proposal 4. </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>IN THE ABSENCE OF DISSENT
OR ABSTENTION BEING INDICATED ABOVE, THE UNDERSIGNED HEREBY CONSENTS TO EACH ACTION LISTED ABOVE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>IN ORDER FOR YOUR CONSENT
TO BE VALID, IT MUST BE DATED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%; text-align: justify; text-indent: 0in; font-size: 10pt">Date:</TD>
    <TD STYLE="width: 46%">
&#8239;<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
&#8239;<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">Signature of Stockholder</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%">&#8239;<DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">Signature (if held jointly)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">
&#8239;<!-- Field: Rule-Page --><DIV STYLE="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 0.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page --></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">Name and Title of Representative (if applicable)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt"><B>IMPORTANT NOTE TO STOCKHOLDERS:</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify; text-indent: 0in; font-size: 10pt">Please sign exactly as name appears hereon. If the Shares are held by joint tenants or as community property, both should sign. When signing as executor, administrator, trustee, guardian, or other representative, please give full title. If a corporation, please sign in full corporate name by a duly authorized officer. If a partnership, please sign in partnership name by an authorized person. </TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>THIS SOLICITATION IS BEING
MADE BY YZI LABS AND NOT ON BEHALF OF THE COMPANY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>PLEASE SIGN, DATE AND MAIL
YOUR CONSENT PROMPTLY IN THE POSTAGE-PAID ENVELOPE ENCLOSED.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %C G(# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/.E=#R'P@9CA< 4 ?HG17YPC]MKXKZA\,?AKH2W83QGXA\4ZWH-]XDT/P_\
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M_P"#&R_^/4?\)OXD_P"A!U'_ ,&-E_\ 'JP**/JWF'M_(W_^$W\2?]"#J/\
MX,;+_P"/4?\ ";^)/^A!U'_P8V7_ ,>K HH^K>8>W\CH?^$V\2?]"'J'_@QL
MO_CM'_";>)/^A#U#_P &-E_\=KGJ*/JWF'M_(Z ^-O$F/^1#U _]Q&R_^.TW
M_A./$W_0@:A_X,K+_P".U@T4?5O,/;^1O?\ "<>)O^A U#_P967_ ,=H_P"$
MX\3?]"!J'_@RLO\ X[6#11]6\P]OY&]_PG'B;_H0-0_\&5E_\=H_X3CQ-_T(
M&H?^#*R_^.U@T4?5O,/;^1O?\)QXF_Z$#4/_  967_QVC_A./$W_ $(&H?\
M@RLO_CM8-%'U;S#V_D;W_"<>)O\ H0-0_P#!E9?_ !VC_A./$W_0@:A_X,K+
M_P".U@T4?5O,/;^1O?\ "<>)O^A U#_P967_ ,=H_P"$X\3?]"!J'_@RLO\
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M.=$T'6=7OD&CZSJ-OIUOJ$4B&W0S*S)*\A8*(L(26!/4=:L_\+6\$^?H4/\
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M=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[!["7<\YHKT;^P=._Y\X?\
MOFC^P=._Y\X?^^:/K$>P>PEW/.:*]&_L'3O^?.'_ +YH_L'3O^?.'_OFCZQ'
ML'L)=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[!["7<\YHKT;^P=._Y\
MX?\ OFC^P=._Y\X?^^:/K$>P>PEW/.:*]&_L'3O^?.'_ +YH_L'3O^?.'_OF
MCZQ'L'L)=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[!["7<\YHKT;^P=
M._Y\X?\ OFC^P=._Y\X?^^:/K$>P>PEW/.:*]&_L'3O^?.'_ +YH_L'3O^?.
M'_OFCZQ'L'L)=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[!["7<\YHKT
M;^P=._Y\X?\ OFC^P=._Y\X?^^:/K$>P>PEW/.:*]&_L'3O^?.'_ +YH_L'3
MO^?.'_OFCZQ'L'L)=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[!["7<\
MYHKT;^P=._Y\X?\ OFC^P=._Y\X?^^:/K$>P>PEW/.:*]&_L'3O^?.'_ +YH
M_L'3O^?.'_OFCZQ'L'L)=SSFBO1O[!T[_GSA_P"^:/[!T[_GSA_[YH^L1[![
M"7<\YHKT;^P=._Y\X?\ OFC^P=._Y\X?^^:/K$>P>PEW/.:OZ#_R&K/_ *Z?
MT-=O_8.G?\^</_?-/AT:QMY%DCM8T=3D,%Y%3+$1::L-46G>Y=HHHKA.P***
M* "BBB@ HHHH K:CIUKJ]A<6-[;QW=G<1M%-!,H9)$(P58'J".U?.L_P'\6?
M\(SHWABWM=+AL;K2-+TR^U&&[,<FE?8KN2XS#&(_W@<2!5 9-I7)XKZ3HH ^
M9-/_ &>/$.K>&;Q-;TO2K+6+'0]/\.:4MGJ$C12+ LT<EW*0B_(ZSY\D@G$0
M4L,Y'IGP)\"^)_AYH]_HVN7L-WIMLXCT_P L@LPWR%Y3A1MWAHR58L=XD8D[
MA7I]% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&=/XA]%%%=IB%%-+JK!2P#'H,\FG4 %%%% !1110 444UVV*6/04 .HKR/\
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MB- <[:^IO-3^^OYT>:G]]?SH"S/G/1?!OAS2=9BO?"-[>:KK$=@=-MM/B4-
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MTTT<0]9&"_SKBKZQMM2A$5PN]58,I#%64CN".0:JQ^'-*C;<;.*1O[TN7/\
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MU"RF&V2WN8Q)&X]U(P:YOP?\(?!G@+S3H7ARQL9)2=\WE^9*1_=WMEMH[+G
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M+JT:E%\M6+B_-6"BBE"EN@S]*LQ$HHHH **** "BBB@ HHHH **** "BBB@
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MUZWQ.VRMLK!1116IQA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQM@IN+JRF@C#' +,A49/;DU,K\KMN:TE&52*GM=7]#YN7_@H-X+90W_".Z\
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M#!<21NS*S%028G=5YP.2.2!UXK3T_P"$/@_2[?4[>TT*W@@U.$6]W&C/MEC
M VXW<9"C.,9QSFK&L?#+PQX@U"^O=0TB&ZNKZ-(;B1V;,B(054X/0%0>.XH
MSX?C=X%N%C,7B6SE$D;2)LW'(#,N.!]XE' 7[QVG -7['XH>%-3AU:6UUVTG
M324$E]L<DVZD'[PQD=",=001U&*H6OP3\%6-C]DM]"CAB\WSP4GE#B3+'S ^
M_<'!=B&!R"QP>:M0_";PG;Z?JUC%H\<=KJKK)>(LL@,C*^\'.[*_-EOE(Y)/
M4F@!^G_%3PEJEK>7-GKUI<V]G;QW4\D;$A(Y "AZ<E@1@#GD<<BLT_&C09M/
M\07]E%?:C8Z((OM-Q;0#8Q=-Y5"[+DHI!;.,9QUR!:T[X.^#])L;NSL]&2WM
M[J"&VD5)Y>(X3NB"G=E-K?,"N"#SUYJ:7X4^%I=$72!IABL%O4U'RX+F:(FX
M3&V0LKAB?E4\GD@'K0!DW7QV\+6^E^(=05[RXM-"EMH+MX+8M^\GV[40=69=
MXW@?=Y'4$"]IWQD\'ZDT@36[>$QR21_OCM5MCE"0WW2. PY^ZRDX#"M&V^''
MA>RDN9+;0K*U:ZO4U*?R(A&);E%"K(P7&2 !U[\]3FL>S^!?@33]-33X/#EN
ME@BQ*EKOD,2>6T;*54M@',,62.6"*&R!B@"7Q!\7-'\.ZI9V$MMJ%S-?0+-9
M&W@#+<EBH")E@=WSCE@%'=@1BLNZ_: \-VL]O&UOJ3"Z-K]GD\A5CD6X5FC?
M<S (N$.2^WMC.170:M\+?#.N:IJ6HWVGR3W>HI%'<O\ :YE#K']S"AP%(R>5
M /S-_>.8(?A#X2MVN/+TME2XNOMDL/VN?RGDP!RF_;LPJC9C9A5&/E& #LJ*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M!I-&3110 JTM%% "-29-%%  #3J** "FY-%% !DTM%% "TUJ** #)I5HHH 6
MDHHH 3)HR:** '4444 -)HR:** %6EHHH 1J3)HHH  :=110 4W)HHH ,FE%
M%% "TC444 )DT+110 ZDHHH 3)HR:** %I:** &DT9-%% "K2T44 (:3)HHH
M ,FG444 %-R:** #)I1110 M(U%% "9- -%% #J*** &Y-&3110 M+110 UJ
A,FBB@!5I:** $-)DT44 &33J** "FY-%% !DT444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %: FT# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,MG_ &E+9);F,2?=WB0;MO7"YK@-6_9K\1R_LL_%R1/AMJ#^.[SXK2:C8/\
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MX?N[MO&&@>$8/ CPR>)/#%U)8XNA=R$6[7*@CE6W%._!H ]9^!_[8WA7XG>
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M2FTJ'5--%D)RBLLC>6ORH[,"Q3[PW L 36;\1_ACKH_;0^(TNE^#M1@D\:^
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MUJO]F-X<D06PLPP?<<)@ E<9)]J /V?HK\U/VI?BKXRM?C!XP\3Z;XXUK6/
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M/_@=%_\ &Z/^$6MO^AY\<_\ @=%_\;JY11]6IA[>93_X1:V_Z'GQS_X'1?\
MQNC_ (1:V_Z'GQS_ .!T7_QNKE%'U:F'MYE/_A%K;_H>?'/_ ('1?_&Z/^$6
MMO\ H>?'/_@=%_\ &ZN44?5J8>WF4_\ A%K;_H>?'/\ X'1?_&Z/^$6MO^AY
M\<_^!T7_ ,;JY11]6IA[>93_ .$6MO\ H>?'/_@=%_\ &Z/^$6MO^AY\<_\
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MNKT[]GG]I%/CUJ=Y$GAB[T6P^R)J-A>2.[K<6[3/$%?,:A9?D#%5+KAOO9!
M[V]^$_@O48O*N?"NDRQ[K1POV90 UJ"+4C&,>4"0N.@)%6?"OPZ\+>!K[4KW
MP[X>T[1+S4G\R\GL8!&T[9+?,1VRS' XRQ..:J,9IZL3<;:(^,OA_P#M,?%!
MX=+U/7=9NSINMV7B(03:AIMFMHUS9QSO;+9M"?-+#R26\]0I"L!R1FG-^V'\
M2I_ VJP7,R:-XQT/P.FI7ZK9QND]U+>V@MKR'<NTK+;7'W?NA]P(&*^O]'^
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MI63]VVYGW;E7CG@GO7ONK>!?#NO^$E\+ZGHUGJ/AU88K<:;<QAX=D>/+&/\
M9VK@]1BLRW^#_@6SL)+&#PCH\-G):W%B]NEJH1K>=@\\1']V1E5F'<@534^C
M$G'JCPGQ=^UQJ-OXOT>YL=(^P^"+'7]2TW4KHW,<EY?BSTJ:[EC%N5S&N\)M
M<-SMYP&&='PK^UUK7C#_ (1NQL?AXRZ[KVJPZ?:P7&HM#:F.6R>\6;SGA!.U
M$964)C(&TL"#7LW_  J#P-_PDY\1_P#"(Z.=?(P=1-HAF(\HQ=<?\\R4/JO!
MS3_#'PE\$^"VLCH7A/2=*^Q7;7]O]EM@ABN#&8C(IZAO+)3V4X&!2Y9]QWCV
M/!+C]N1=)T%M8U7P2\%C>6E_-I/V35%GDN9;2]CM)$F0)F!6>5&#?-QGC. =
MFS_:F\2>(IK'2=%^'Z#Q#-9:M=7*:EJ36UO;K8O&C2(6A#R(_G(5!13U! P:
M[WP#^S9\/_A_H%_ID/A^QU634DGAU"^U"UC>>]BEF:9HY2!@J&;_ ,=7.2,U
MU6@_#'PAX7AM8M(\-:;IJ6MM/9P"W@"E(9F#3(#U(=E4MGJ0,TE&IU87AT1\
MU_#']K7Q+I?@/1)_%>D_\)'<6]CI.I>(]86]A@D@35)S':BUMUB7S@HP6'!
MXW.PS6_=?M?>((]'M]2MOAU!/;7LNNBR\S7 ADATE7:YE<>4=F?+(5>22><#
MFO;)/@[X%FU'0;]_"&C/>Z#$D.E7#6BEK*-#E%C/8*>5!^Z>1BK8^&OA,6EO
M:CPYIOV:W%VL,7D#;&+K(N@!V\W<V_\ O9-'+/N'-'L>#6O[66H:YJ6C03^'
MYO#LXU*S:6UBO(KI;JSNM*GOX0[E!L;$8#!.0<88C-+H_P"V9>ZEI^GK/X&C
ML]8UN'0KC1+5M84P31ZHTJPFXF\L>3L\ERV%;JH')Q7NJ_"_P>MPDX\,Z8)D
M\G;)]G&1Y4+018_W(6:,>BL17/>.O@#X5\9^$)]!M;2#PZLEO:6:W5A9P2%;
M>U<O! 8Y59&B4DX4CC/!%/EGW"\>QH?!?XFGXN^!%\1-I@TB3^T+W3WM%N5N
M%5K:X>!F$B@!@3&2"!WKN*Y#X3?#'3/@[X$L?"VD337-I;2S3M<7"HKRRS2M
M+(VU %4%G.%4  8 KKZUC>RN0[7T"BBBF2%%%% !1110 4444 %%%% !1110
M 5T?@?\ Y"%S_P!<A_.N<KH_ _\ R$+G_KD/YUA6_ALVI?&CLZ***\8]4***
M* /.Y- U$R.19R$%B>WK]:;_ ,(_J7_/G)^G^->C45V_6I=CD^KQ[GG/_"/Z
ME_SYR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N><_\(_J7_/G)^G^-'_"/ZE_
MSYR?I_C7HU%'UJ?8/JT>YYS_ ,(_J7_/G)^G^-'_  C^I?\ /G)^G^->C44?
M6I]@^K1[GG/_  C^I?\ /G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_PC
M^I?\^<GZ?XT?\(_J7_/G)^G^->C44?6I]@^K1[GG/_"/ZE_SYR?I_C1_PC^I
M?\^<GZ?XUZ-11]:GV#ZM'N><_P#"/ZE_SYR?I_C1_P (_J7_ #YR?I_C7HU%
M'UJ?8/JT>YYS_P (_J7_ #YR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N><_\
M(_J7_/G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_PC^I?\^<GZ?XT?\(_
MJ7_/G)^G^->C44?6I]@^K1[GG/\ PC^I?\^<GZ?XT?\ "/ZE_P ^<GZ?XUZ-
M11]:GV#ZM'N><_\ "/ZE_P ^<GZ?XT?\(_J7_/G)^G^->C44?6I]@^K1[GG/
M_"/ZE_SYR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N><_\(_J7_/G)^G^-'_"
M/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_ ,(_J7_/G)^G^-'_  C^I?\ /G)^G^->
MC44?6I]@^K1[GG/_  C^I?\ /G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YY
MS_PC^I?\^<GZ?XT?\(_J7_/G)^G^->C44?6I]@^K1[GG/_"/ZE_SYR?I_C1_
MPC^I?\^<GZ?XUZ-11]:GV#ZM'N><_P#"/ZE_SYR?I_C1_P (_J7_ #YR?I_C
M7HU%'UJ?8/JT>YYS_P (_J7_ #YR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N
M><_\(_J7_/G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_PC^I?\^<GZ?XT
M?\(_J7_/G)^G^->C44?6I]@^K1[GG/\ PC^I?\^<GZ?XT?\ "/ZE_P ^<GZ?
MXUZ-11]:GV#ZM'N><_\ "/ZE_P ^<GZ?XT?\(_J7_/G)^G^->C44?6I]@^K1
M[GG/_"/ZE_SYR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N><_\(_J7_/G)^G^
M-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_ ,(_J7_/G)^G^-'_  C^I?\ /G)^
MG^->C44?6I]@^K1[GG/_  C^I?\ /G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/J
MT>YYS_PC^I?\^<GZ?XT?\(_J7_/G)^G^->C44?6I]@^K1[GG/_"/ZE_SYR?I
M_C1_PC^I?\^<GZ?XUZ-11]:GV#ZM'N><_P#"/ZE_SYR?I_C1_P (_J7_ #YR
M?I_C7HU%'UJ?8/JT>YYS_P (_J7_ #YR?I_C1_PC^I?\^<GZ?XUZ-11]:GV#
MZM'N><_\(_J7_/G)^G^-'_"/ZE_SYR?I_C7HU%'UJ?8/JT>YYS_PC^I?\^<G
MZ?XT?\(_J7_/G)^G^->C44?6I]@^K1[GG/\ PC^I?\^<GZ?XT?\ "/ZE_P ^
M<GZ?XUZ-11]:GV#ZM'N><_\ "/ZE_P ^<GZ?XUN>$M,N[&]G>X@:)6CP"V.3
MFNJHJ)8B4XN+14:$8N]PHHHKE.D**** "N-UCXP>#] \8P>%M0UJ*VUN8QJ(
M6CD*(T@8Q(\@78C.$;:K,"V.,UV5>#?$_P"&_C7XA?%:WBN]+TV?X=01(T/D
MZB8+@WI1E-W/'Y1\WR0P\N/>!N^8G(7 !UL?[27PXGT6XU2+Q(DMI#/';D):
MSM*[2*S1F.()OD5E1V#H"I5&(. :N'X]^ OM-U"OB*WD-OIZZFSQH[1M RHR
ME'"[78K+$=BDMB1>.17BNA_ OXCZ)K_ACQA]@T&?6_"=C9:+9:2NH.L.H6\-
MM<P/<-+Y7[IF-R&5-K8","?FJ:^_95U/2_"/A6VT,647B71](0W.L),R?:KR
M+R_)C16!5%R"WF%2?W,(((&  ?4:MN4, 1D9Y&#2US/PULO$.F^!=&MO%5TM
MYK\<.+J96#9.3M!8*H9@NT%@ "03@9KIJ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJCA5^1.F/NCTKHZ* *&@Z#I_A?1[32=)M([#3K2,106\(PJ*.P_Q[YJ_110
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MZ<T7\FK_ (NWW/T"]!]&ON+!E01ERZA,9W9X_.H&U2S2(R-=0B,=6\P8K/\
M^$6MO.4!Y!9 [S99_=;O7'I[=*N+H>G+()!8VX<="(Q253'2^Q&/JV_FK+;U
ML_0.6@OM-_(@?Q1I:J"+M9,]HP6(]R .*:WBK31]R<S'' BC9L^W ZUIK!'&
MQ98U5FX)"@$TVXN(-/M9KB9EA@A1I)'/ 50,DG\*?L\<_P#EY%?]NO\ ^3#F
MH_RO[U_D9*R:[>1F6(6UHC_=BF4ET'8G'&3Z>]<GX36?Q=\1=7UF^2-H-&0:
M;9JAW1K,?FG93Z_=4GZBH/#NC^(?'VEC6KOQ/J.D6>HR-+%I]I'&FRV)/E@.
M5W!BN"3[UWWA_P /V/A?28--TZ'R;6$' )+,Q)R68GDDDDDFM*.%=*7,ZDI/
MS>GK;I\M/PM,ZO,K**1HT445W&!7U"PM]4L9[.[A6XMIT,<D3C(92,$&H](T
MFTT'3+;3["!;:SMD$<42=%45<HH **** "BBB@ HHHH **** "BBB@ HHHH
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M:A_8^N1Q^2TC1^9#<1CHDJ9&<9."#D50DM?B191N(K_P_J1VEPTUO+"V1_
M&(P?4FN\HH X>'XJ61\*6FJ/9W,FH33_ &$Z3 H:<70SNBP2.F"<GC&#44OQ
M.O+B$Q:?X/UZ;4C\HAN;80Q*W^U(3@ >HS6JWP[TC_A-H_%"1M'?JC*R*?W;
MN0%\PK_?"Y7/H:ZB@#RR34/'/B_6'TE8_P#A$9=/A,\]W%B>&ZD8CRE1B/N<
M-N[]JNWG@OQ=XNA^S^(M>L[;2YBJW6FZ7;G$D8Y*^:WS#<>O'3BO1J* &0PI
M;Q)%&H2-%"JJC  '  I]%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#>W'V.SGGQ
MN\J-GP2!G SU/ J:FR1I-&T<BJ\; JRL,@@]010!\E^#OC)\3=9U30/!6M:I
M_P (]XU\02PW3376EVLL%C9M;74P: Q3.LV][?R_G(("L<'(J%/VBOB.NDZ)
MXDU".STWP_XBTF 6<\=NLL<%PRQF6X503*Y7%PWEE=I'D@$EC7NT?[.WPVAT
M.[T>/PAI\>G74T<\D2JP.Z,$1[6SN4*&8!5( #, ,$UO:E\,?"NK6,-E=:):
MR6<.GMI4-N%*I%:MLS&B@@*/W:<C!&P8/% &EX5\3:=XP\.V.L:5<F[L+I-T
M<S(48X)5@RD JP8$$$ @@BM:L[P]X>T[PIHMII&DVD=CIUHGEPV\><*.O4\D
MDDDD\DDDUHT %%%% !1110 4444 %%%% !1110 4444 5[^Q@U2QN+.YC$MO
M<1M%(C=&4C!'Y5P=K\#/#UK:P0I/J@"@+<,M_(#=J/X9.>1P.F.E>B44 <?I
M7PC\*:-J4=];:4OGPR"2#S)'=8"/^>:DD+SSQWKI;?2;&UNGN8;*WAN)/OS1
MQ*KM]2!DU;HH P_%WA.U\7Z:MM/));3PR":VO+<[9;>4='4_T[CBN3O/AWXJ
MO+JWU*7QFSZK9-BTVV@CMPIX?S(P?G+#OD8QQ7I%% '":/JNOZ!XTM=%U_4X
M-4M]1M7EM+B.U$!$L9&Z,@$@_*<CZ&M!?BAX<6WUF>?48[:'2;K['<M)V?C&
MT#).<D#'H?2M+Q1X3T_Q=8I;7\;[HG\R"XA<I+!(.CHPY!K!\._!_P .:!<6
M-XUK]NU*UCV?:[CDR,6+&1EZ%\L?FZT :VF_$+PQJWF?9-?TZ<Q_>VW*#'YF
ML[Q'\4M$TK2+^?3]0L]5U&';'%8V]PK/)*Y"HN >Y(SZ#-:U]X'\.ZDL8NM"
MTZ<1_<WVJ';].*?'X+T"&2VDCT33XY+5MT#K;(#&?52!Q0!S:6/Q'O$59=3T
M'3L?/YEO;22L>^PAF  [9'-.?P_X\O\ ;#<^*=/LH&.7DT_3R)A[*78C\<5W
M=% '"_\ "(^,X5,</CC?%_"UQID3R?0D$#'X5T'@WPVOA'PSI^D+-]H^RQ[6
MFV[=[$DLV.V236U10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MMN3YR_N3Z/S\OXU/:7D%_;I<6L\=S XRLL+AE;Z$<&@":BBB@ HHHH ****
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M-;K1=2DBD\#>)]?-I>27\FI?9F%S?Z"-%%NM@9LJWG/*%0P9!# OQUK[8HH
M^#+SX:W^M>$;77/^$.\2:1J\E[?:A#X=T_PI#)IEE>M9PPVUNUM<(=T>U,-<
M*H#.9"2F17W%X;^W?\([I?\ :D$-MJ7V6+[5#;?ZJ.78-ZI_LAL@>PK1HH *
M*** "BBB@ HHHH Y/XK6MK>_#W6X;[P]<^*[)H1Y^C6F#+=)N4LJJ64,<9.W
M/S8V\YQ7SY\"?A;J^L2-H_B#2-5TSPS9'6+JSNY(6TN:X^VS*JE84(^S%8Q<
M*$3;A74X4MBOJ^B@#XXA\%:MX=^#_A.#6?ASJGBJT\(^&(TM?#,<3LUS?SW2
MJB.!DLD4< 9P<_+(<ALX/.R?"?6X]-M%L_#&M:AJ.J640TB\.D-9Q:'JAU9[
MFY9(FYLX KQE&XW)$5R2<'[IHH ^'I_A_!XUB\9W)\ ^+O!FFM/;6::7IVA;
MY[FSCU$3R7<[3[ENY9'&[RP'9(B0 Q8BOIS]GZTUFP^%>E6VMZ<NEW,4EPL%
MN+*.R?[-Y[^0\D$8"12-'L9E4 !B>!TKT6B@ HHHH **** "BBB@ KYF_:)\
M(:O>?%S0O$6BZ)JVL:U9V-M!IL3:/;7VE,WVP/.)I'!>W<1@'>I3HNTDC;7T
MS10!\UV_PKOSJ7PG\8W>D:BVO0Z_?ZOJ4*R.5LTNK>[=M\0.W>-T$6X@D8"C
M&:X.;P+?7GB[PEIU[X'UFQUF^>W\0:SXQATJ6Y=;M[B2>*QAE&1;*CR?OI./
MD&WG.5^T** /A&S\(ZMX5\/PW"_"+5-6N+72M+TJ[T^ZTQY+>XUQ);@RZE+$
MAS<Q1H[,9,-YA= #D97H?"OPMU+PK\0_ EWH&D>)=2NK:VTBR2?Q%H%O]C2P
MC,INI/-<&6SE4R.1&&4Y\L .IR/LJ25(8VDD=8T49+,< ?C38KJ&=$>*:.1)
M/N,K AL>GK0!+14#WUM'(B/<1*[G:BLX!8], =ZGH **** "BHYIX[:,R32+
M%&O5W8 #\34,FJ64*HTEW!&L@W(6E4!AZCGD4 6J:Z+(C(ZAE88*L,@CTJ(7
MULTD48N(C),N^--XRZ^H'<?2IZ /E[PC\&WCU"YOHO!\7A^3Q5XN5[V"UL4M
MX[71].9VM4=4  \UX4?U8W!]!3;'X5W>A0>)?#G]AZU-X;OO'-QKEVV^2>6[
MM(K&&;AV;<QEN45%Y'*D#&*^HZ* /ACPQX':]BL?%&H_"[6['06U$'4O D6A
M/Y=M MA<069$3#_2Y5=P99AT9U[(&J?P[X!UN;6=$T74O!'B'2=9T;1%:X\2
M6NG--<:MJ+:6\"PK>,?+B@A1@F&8*\H7@ %F^VKF\@LT#W$T<"$X#2.%'ZU"
M=:T\8S?6PW $?OEY!Z'K0!X?^R3X9U'PAH>NZ7_9%YIOAJW:T32Y]7T>#3-1
MG86ZK/YT<2J&"N %D(R?FY8 $^^4P31L%(=2&.%Y')]J?0 4444 %%%% !11
M10!YS^T/X;N/%OP9\3Z7:PW=S<2PHZV]E )Y)MDJ.8S$67S$8*59 P+*6 Y(
MKQ7X'_"OQ#XAO[^U\5Z5=:/X;+ZK?V,-G!+IBQ+>/'"L<,>[?!B.*X;;D,!<
M9."V*^L** /C>'P5JOA_X/\ A.'6?AQJGBJW\(^%X8[7PRD+LUQJ$]TJJK@$
MEDBC@5G!W?+(<ALX//M\)];CT^R6S\,:UJ&I:G90C1[XZ0UG%H>I?VL]S=,D
M3<V<(5XRA_B2+;DG@_=%% 'P[-\/X/&T/C&Z/@'Q=X+TUKBVLUTG3M!WSW%G
M%J(G>[G:<,MW+)(-WE@.R1$@!R6%?3O[/]KK5C\*=)MM=TY-+NHGN%AMQ91V
M;_9O.?R&D@C 2*1H]C,J@ ,3P.E>BT4 %%%% !1110 4444 %?-WCCX'_P!L
M>)/CBBZ=JUQ8^*/#5HPE6\F!O+N/[9^XC8/E5 ,(\M<+A@,<FOI&B@#Y?\2?
M"74_B!\-?&=EK&CZDLEGX(M-$TVTAD>"2YG6V,\J H064RF",KG#&(@Y%9WQ
M*T35[?3YM8O?AY=^,+^UBTK0M&LY=/DNK>T9;=I+B]F@7F6)'F*[<'<\0 Q]
MX?6-% 'Q!I?PHO\ P[J6E6D'A7Q1K'D7&F7EKKD]BT5R-'@TYHKNT+9#0R._
MG*+?(),R$=,C/MOAO_PDG@Y-6NO!'BSPDL^L17C>&=)\,1S0:>(K&6&T1X+A
M6%R?F_>3*I&\J#A5#5]WT4 <S\,EUE/AUX97Q#96VG:ZNFVXO;2S0)##,(UW
MHBKPH!R,#@=!Q73444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!5U3[5]AF^Q
M!3=8_=[^F<UST3>+/,3>MKLW#=C'3/-=717EXK _6JBG[:<+=(RLOR.FE7]G
M%QY$_5'DG[6.C7_B#]GOQAI^F6<]_>30P[+>VM6NG<"XB+8B7F0!0Q*CJ 17
MS5X?^$?C#Q%K5A'H,&H:%#:>++C6]&UN+19M'LTF72MJJ]@Q)C@,J^4^>)3(
MQ S7WA17J',?F]XC\%^,_%EG)?ZYX.U70=5U+2==$=E-X8FUEH+V7599$BAD
M1@+=BN"D^?NE6[5^A?A$WA\*:*=0MGL[_P"Q0_:+:2;SFBD\M=Z%_P",@Y&[
MOC-:U% ',_$1O$Z^&93X06W?6O,38+K&S9GYNOM7G7AV7XWG7M.&KPZ.-*\]
M/M1B*;_*S\V.>N*]KHKR,3E_UBLJWMIQM;2,K1=NZM]Y[6%S/ZK0E0]A3G>^
MLHWDK]G?IT/%/VN]%O=>^$4=O964U_LUO3)IXH=,?4L0I=QM(S6R?-,@4$E!
MU ->*:!\&Y/$'PKMX-5\%?VIY'Q!MIK"6XT1K,MIDEW \S1V;Y:U@_UBF,G!
M"LW1J^UJ*]<\4^3F\':1X=\>>)['7?AUK/B#Q+-XBM)O#-]I=I(D-OIR) (%
MBNUPEK'!MEWQDKNYX;?7UC110!QGQ*;QHMK8_P#"&)://YC?:?M>W&W'RXR?
M6L+P+)\4F\20#Q1%IJZ-L?S#;%-^['RXP?6O4** /G7]KC0;G6-4^&<XT][W
M3+/5+M[V1O#LNNPPJUG*J&2UC(+9<@!L_*2#6?\ \*B\.^*/$_P6U0>#+*^M
M83?)J%TWALZ<B*MK((?,MY 6B7S,;58GG!'6OIJB@#Y"^&?P\^(VEM\'I]4N
MYYM%L_%&J3RZ,=':*:PB==0$<DT_F$E#O3&4 /F+[5]>T44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%4=:U0:+I5S?-:W5Z($WFWLH3+,_LJ#DGVH O45Y[_ ,+DA_Z$
M_P 8_P#@CEH_X7)#_P!"?XQ_\$<M 'H5%>>_\+DA_P"A/\8_^".6C_A<D/\
MT)_C'_P1RT >A45Y[_PN2'_H3_&/_@CEH_X7)#_T)_C'_P $<M 'H5%>>_\
M"Y(?^A/\8_\ @CEH_P"%R0_]"?XQ_P#!'+0!Z%17GO\ PN2'_H3_ !C_ .".
M6C_A<D/_ $)_C'_P1RT >A45Y[_PN2'_ *$_QC_X(Y:/^%R0_P#0G^,?_!'+
M0!Z%17GO_"Y(?^A/\8_^".6C_A<D/_0G^,?_  1RT >A45Y[_P +DA_Z$_QC
M_P"".6C_ (7)#_T)_C'_ ,$<M 'H5%>>_P#"Y(?^A/\ &/\ X(Y:/^%R0_\
M0G^,?_!'+0!Z%17GO_"Y(?\ H3_&/_@CEH_X7)#_ -"?XQ_\$<M 'H5%>>_\
M+DA_Z$_QC_X(Y:/^%R0_]"?XQ_\ !'+0!Z%17GO_  N2'_H3_&/_ ((Y:/\
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M/_@CEH_X7)#_ -"?XQ_\$<M 'H5%>>_\+DA_Z$_QC_X(Y:/^%R0_]"?XQ_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
K **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
